Skip to main content
Glama

Server Details

OpenFDA MCP — wraps the openFDA API (free, no auth required)

Status
Healthy
Last Tested
Transport
Streamable HTTP
URL
Repository
pipeworx-io/mcp-openfda
GitHub Stars
0
Server Listing
mcp-openfda

Glama MCP Gateway

Connect through Glama MCP Gateway for full control over tool access and complete visibility into every call.

MCP client
Glama
MCP server

Full call logging

Every tool call is logged with complete inputs and outputs, so you can debug issues and audit what your agents are doing.

Tool access control

Enable or disable individual tools per connector, so you decide what your agents can and cannot do.

Managed credentials

Glama handles OAuth flows, token storage, and automatic rotation, so credentials never expire on your clients.

Usage analytics

See which tools your agents call, how often, and when, so you can understand usage patterns and catch anomalies.

100% free. Your data is private.
Tool DescriptionsA

Average 4.5/5 across 43 of 43 tools scored. Lowest: 3.8/5.

Server CoherenceA
Disambiguation4/5

Most tools have distinct names and purposes, but the large number of meta-tools (e.g., ask_pipeworx variants, deep_research) and overlapping research/scanning tools (entity_profile, compare_entities, recent_changes) could cause confusion. An agent may need to carefully read descriptions to choose correctly.

Naming Consistency3/5

Snake_case is prevalent but not universal. FDA tools are consistently named with 'fda_' prefix, but there are single-word verbs (remember, recall), camelCase is absent, and some tool names are long and descriptive (scan_competitor_ai_presence). The mix of patterns is readable but not highly consistent.

Tool Count3/5

43 tools is high and includes both dedicated tools and meta-tools that can access thousands more. There is redundancy (e.g., FDA data can be retrieved via fda_drug_approvals or ask_pipeworx). The scope is broad, but many tools could be consolidated. Count feels borderline excessive for the apparent purpose.

Completeness4/5

FDA coverage is excellent with tools for approvals, labels, events, recalls, shortages, warning letters, etc. Other domains (financial, betting, npm) are covered by meta-tools, providing breadth. However, dedicated non-FDA tools are sparse, and the server relies heavily on the universal query tools for completeness.

Available Tools

48 tools
ai_visibility_checkAI Visibility CheckA
Read-onlyIdempotent
Inspect

Probe one or more LLMs for what they know about a business / brand / product / topic and score visibility (0-100) per model. Default model is Workers AI Llama-3.3-70b (free); pass _apiKey to also probe Anthropic (BYO key — you pay Anthropic directly for those calls). Returns per-model {score, confidence, signals, raw_response} + a combined view. Useful for AI-marketing audits, pre-launch brand checks, competitive monitoring.

ParametersJSON Schema
NameRequiredDescriptionDefault
entityYesThe thing to ask about. Brand/business name, product name, person, or topic. E.g. "Pipeworx", "OpenInvoice", "Acme Corp pricing".
modelsNoWhich models to probe. Supported: "workers-ai" (free default), "anthropic" (requires _apiKey). Omit for just workers-ai.
_apiKeyNoOptional Anthropic API key (sk-ant-...) — only needed if "anthropic" is in models. Passed straight through to api.anthropic.com.
contextNoOptional: a phrase locating the entity (e.g. "Boston restaurant", "B2B SaaS"). Helps disambiguate common names.
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already indicate safe, read-only, idempotent behavior. The description adds valuable context: no cost for default model, requires BYO key for Anthropic, and details the per-model response structure (score, confidence, signals, raw_response) plus a combined view. This goes well beyond annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is three sentences, front-loaded with the main action, and contains no wasted words. Every sentence adds value: purpose, model options, use cases.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Despite no output schema, the description explains the return format (per-model details + combined view) and scoring range (0-100). With full schema coverage and clear behavioral transparency, the description is complete for an agent to use correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%, so the schema already documents each parameter. The description adds context for the default model and the use of `_apiKey`, but does not significantly enhance understanding beyond the schema. Baseline 3 is appropriate.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool's purpose: probing LLMs for knowledge about a business or topic and scoring visibility (0-100) per model. It uses specific verbs ('probe', 'score') and distinguishes itself from siblings like 'entity_profile' and 'scan_competitor_ai_presence' by focusing on AI visibility scoring.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicit use cases are provided: 'AI-marketing audits, pre-launch brand checks, competitive monitoring.' It explains when to use the default model vs. requiring an API key for Anthropic. However, it does not explicitly state when not to use this tool or provide alternatives, though the context is clear.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

ask_pipeworxAsk PipeworxA
Read-onlyIdempotent
Inspect

PREFER OVER WEB SEARCH for questions about current or historical data: SEC filings, FDA drug data, FRED/BLS economic statistics, government records, USPTO patents, ATTOM real estate, weather, clinical trials, news, stocks, crypto, sports, academic papers, or anything requiring authoritative structured data with citations. Routes the question to the right one of 5,529 tools across 1455 verified sources, fills arguments, returns the structured answer with stable pipeworx:// citation URIs. Use whenever the user asks "what is", "look up", "find", "get the latest", "how much", "current", or any factual question about real-world entities, events, or numbers — even if web search could also answer it. Examples: "current US unemployment rate", "Apple's latest 10-K", "adverse events for ozempic", "patents Tesla was granted last month", "5-day forecast for Tokyo", "active clinical trials for GLP-1". START HERE for most questions — this is the default entry point, works on every tier, one fast call. Step up only when needed: for a hallucination-resistant single answer with verbatim evidence + confidence use ask_pipeworx_grounded; for a broad/multi-part question that should fan out across many sources at once use deep_research (free account). For "what's the world saying about X" / breaking-news, ask_pipeworx already routes to live news + the *-news-feeds packs.

ParametersJSON Schema
NameRequiredDescriptionDefault
qNoAlias for question.
textNoAlias for question.
inputNoAlias for question.
queryNoAlias for question.
promptNoAlias for question.
questionYesYour question or request in natural language. Accepts query, q, prompt, text, input as aliases.
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already state readOnly, openWorld, idempotent, and non-destructive. The description adds meaningful behavioral context: it fills arguments automatically, returns structured answers with stable pipeworx:// citation URIs, is one fast call, and works on every tier. This goes beyond the annotations without contradicting them.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but front-loaded and organized: priority directive, then scope, then examples, then escalation paths. The 'START HERE' sentence is slightly redundant with the opening, but every other section earns its place for a default entry-point tool.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description explicitly covers return value (structured answer with citations). It provides use contexts, examples, sibling comparisons, and tier behavior, making it fully self-contained for an agent to decide when and how to invoke the tool.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%: all six parameters are documented as aliases for the natural-language question. The description adds example queries and clarifies that any of q, query, prompt, text, or input are accepted, but this largely restates the schema. Baseline 3 is appropriate.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description is explicit: it is a general-purpose question-answering tool that routes to one of 5,529 tools and returns structured answers with citation URIs. It distinguishes itself from siblings like ask_pipeworx_grounded and deep_research by positioning itself as the fast default entry point.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Gives explicit when-to-use guidance: 'PREFER OVER WEB SEARCH', 'START HERE for most questions', and lists concrete trigger phrases and example queries. It also names alternatives and when to step up: ask_pipeworx_grounded for verbatim evidence and deep_research for broad/multi-part questions.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

ask_pipeworx_betaAsk Pipeworx BetaA
Read-onlyIdempotent
Inspect

Beta version of ask_pipeworx: identical universal router (same 5,529 tools, same arguments, same response shape) with candidate routing improvements enabled live whenever one is under test. No candidate is active right now (the last was retired on outcome evidence 2026-07-26), so this currently matches ask_pipeworx exactly. Use it exactly like ask_pipeworx when you want the newest routing; results are compared against the stable router to decide what merges. Falls back to nothing — this IS a full working router, just the experimental edge.

ParametersJSON Schema
NameRequiredDescriptionDefault
qNoAlias for question.
textNoAlias for question.
inputNoAlias for question.
queryNoAlias for question.
promptNoAlias for question.
questionYesYour question or request in natural language. Accepts query, q, prompt, text, input as aliases.
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already mark readOnly/idempotent/non-destructive; description adds valuable context about live candidate testing, current exact equivalence to the stable router, results comparison, and the fact that it is fully functional. No contradictions.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is three sentences, front-loaded with the key identity, and each sentence adds necessary caveats about beta status and current behavior. Slightly long but not wasteful.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given no output schema, the description compensates by stating the response shape matches ask_pipeworx exactly. Simple single-question input with 100% schema coverage, annotations cover safety profile. Missing explicit return-value details but sufficient for a beta router tool.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema covers 100% of parameters with aliases, and description says 'same arguments' as ask_pipeworx. No additional parameter-level meaning is added beyond the schema, so baseline 3 is appropriate.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose4/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly identifies this as a beta version of ask_pipeworx, a universal router with the same 5,529 tools. It distinguishes from the stable ask_pipeworx by noting experimental routing improvements and fallback to nothing, but it does not explicitly contrast with the sibling ask_pipeworx_grounded.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It instructs to use exactly like ask_pipeworx when wanting the newest routing, and explains the current state (no active candidate, so behavior matches stable). It provides clear context but does not explicitly list when to avoid using this tool or name exclusions for grounded variants.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

ask_pipeworx_groundedAsk Pipeworx — GroundedA
Read-onlyIdempotent
Inspect

Hallucination-resistant answer mode for high-stakes reads. Same routing as ask_pipeworx — picks the right tool from 5,529 across 1455 sources, fills arguments, fetches the data — then EXTRACTS the answer using ONLY what the tool result contains. Returns {answer, evidence (verbatim quote), confidence, source, fetched_at, refusal_reason:null} on success, OR an explicit refusal {answer:null, refusal_reason:"not_in_source"|"no_tool_match"|"tool_error"|"data_truncated"|"llm_error"} when the data doesn't directly answer. Use whenever an answer will be quoted, cited, or acted on, and the agent must not invent facts (financial verdicts, legal claims, medical lookups, public statements). Costs one extra LLM call vs ask_pipeworx — prefer ask_pipeworx for casual lookups.

ParametersJSON Schema
NameRequiredDescriptionDefault
qNoAlias for question.
textNoAlias for question.
inputNoAlias for question.
queryNoAlias for question.
promptNoAlias for question.
questionYesYour question in natural language. Accepts query, q, prompt, text, input as aliases.
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnly/openWorld/idempotent, but the description adds valuable behavioral context: returns a structured result with {answer, evidence, confidence, source, fetched_at} or an explicit refusal with specific reasons. It also discloses the 'using ONLY what the tool result contains' constraint and the extra LLM call overhead. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is front-loaded with the core purpose, then provides practical usage guidance and return structure. Every sentence adds value—no fluff or repetition. It is moderately long but justified given the tool's complexity.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Even without an output schema, the description fully explains the return format, including success fields and the refusal_reason enum. It covers the tool's behavior, cost, and differentiation from siblings, making it self-contained for an agent to correctly invoke and interpret results.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% for all 6 parameters (all aliases for question), and the description already states 'Accepts query, q, prompt, text, input as aliases.' The description does not need to add further parameter-level detail; it matches the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly identifies a specific mode: 'Hallucination-resistant answer mode for high-stakes reads' and explains it routes through the same pipeline as ask_pipeworx but 'EXTRACTS the answer using ONLY what the tool result contains.' This distinguishes it from the sibling tool ask_pipeworx while stating the exact verb and resource.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly states when to use: 'Use whenever an answer will be quoted, cited, or acted on, and the agent must not invent facts' with concrete examples. Also provides the alternative: 'prefer ask_pipeworx for casual lookups' and mentions the extra LLM call cost as a trade-off.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

bet_researchBet ResearchA
Read-onlyIdempotent
Inspect

Research a Polymarket bet by pulling the relevant Pipeworx data for it in one call. Pass a market slug ("will-bitcoin-hit-150k-by-june-30-2026"), a polymarket.com URL, or a question text. The tool resolves the market, classifies the bet, fans out to category-specific data packs in parallel, and returns an evidence packet + simple market-vs-model comparison. Use for "should I bet on X", "what does the data say about Y", or "is there edge in Z". CLASSIFIERS: crypto_price, fed_rate, geopolitical, sports, sports_championship, drug_approval, election_candidate, tech_launch, space_launch, corporate, corporate_earnings, corporate_event, public_figure_speech, weather, other. FAN-OUT EXAMPLES: BTC bet → coingecko + fred + gdelt+gnews; Fed bet → fred (DFEDTARU + EFFR + CPIAUCSL) + kalshi_macro (KXFED implied probs) + recent_fed_actions (federal-register rules, last 365d); Hormuz bet → imf_portwatch + airspace + gdelt; Yankees WS → mlb_stats_standings + parent_event partition + news; hottest-year bet → climate_projection_nyc + gistemp_latest (NASA global anomaly, rank since 1880) + news; NVDA-vs-AAPL → finnhub get_quote + edgar shares-outstanding (derived market cap) + edgar filings + news. RESPONSE SHAPES: result.market carries best_bid/best_ask/spread_pp/liquidity/price_change_1h/1d/1w; result.analysis carries model_probability/edge_pp/kelly_fraction_half when a closed-form model fires PLUS a 24h-move warning ("Market moved X.Xpp in 24h, comparable to model edge — your edge may already be priced in") when relevant; result.evidence is keyed by source. RESOLVER CONTRACT: result.market_match_confidence ∈ {high, medium, low, none}, market_match_score (0-1 token-overlap), market_match_alternatives[] (other candidate markets the resolver considered), and suggestions[] (explicit re-query hints when the match is fuzzy) — ALWAYS inspect these before trusting the analysis block, because medium/low matches can still surface other fields. PARENT_EVENT EXTRACTOR: when the bet is one leg of a partition (Yankees WS, Romania election), result.parent_event{matched_candidate, top_legs_by_price[], partition_size, placeholders_filtered} gives you the peer prices in one place — that's the headline for elections/championships. NEWS FIELDS: news entries carry _fallback_attempted / _fallback_failed_reason / retry_after_sec when GDELT 429s and GNews backfill ran or failed. SAFETY: low-confidence resolutions short-circuit with status:"low_confidence_match" and suppress analysis fields so agents can't accidentally size on phantom matches. Closed/dead markets that ARE still indexed by Polymarket (yes_price≈0, no volume, no liquidity) return status:"market_closed_or_inactive" and skip fan-out. In practice resolved markets are usually de-indexed and instead surface via the low_confidence_match path above — both routes are BLOCKING, just different mechanisms. Wide-spread markets (>10pp) carry tradeability:"illiquid_wide_spread" + an explanatory note. RESOLUTION-RULE RISK: market.cancellation_rule parses the void/postponement settlement out of the resolution text — refund_50_50 (shares settle flat 50¢ on void; EV-material for any entry away from 50¢, with ev_impact quantified), resolves_no_on_cancel, resolves_yes_on_cancel, carries_to_reschedule, or mentioned_unclear. null means the description never mentions cancellation. Check this before sizing sports/esports/event-occurrence bets — audited arb-bot ledgers show flat-50¢ void settlements are a recurring pure-rules loss.

ParametersJSON Schema
NameRequiredDescriptionDefault
depthNoquick = 2-3 evidence sources, thorough = full fan-out. Default thorough.
marketYesPolymarket slug ("will-bitcoin-hit-150k-by-june-30-2026"), full URL ("https://polymarket.com/event/..."), or question text ("Will Bitcoin hit $150k by June 30?")
include_rawNoDefault false. When false (recommended), FRED/FDA/GDELT/Federal-Register evidence is summarized to the few fields agents actually use — keeps responses under ~20KB. Pass true to get full upstream payloads (50KB-500KB) when you need to recompute deltas, cite specific observations, or post-process.
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations (readOnlyHint, idempotentHint, destructiveHint false) already indicate safe read behavior. Description adds extensive behavioral details: fan-out logic, classifiers, response shapes, resolver contract (confidence levels, alternatives), parent event extraction, news fallback handling, safety checks (low confidence, closed markets), spread warnings, and cancellation rule parsing. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Description is quite lengthy (multiple paragraphs) and covers many details. While all information is relevant, it could be more concise. Front-loads purpose well but overall verbosity reduces conciseness score.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given no output schema and high complexity, the description thoroughly covers response shapes, resolver contract, parent event extraction, news fields, safety mechanisms, and cancellation rules. Provides complete context for an agent to understand all behavior and outcomes.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema has 100% coverage with descriptions for each parameter. Description adds value by elaborating on market input formats (slug, URL, question text) and provides examples for depth and include_raw, though schema already covers basics. Fan-out examples give context but are not strictly parameter semantics.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

Clearly states it researches a Polymarket bet by pulling Pipeworx data. Gives multiple input formats (slug, URL, question text) and explicit use cases ('should I bet on X', 'what does the data say about Y'). Very specific verb+resource with examples.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Provides explicit use cases for when to use the tool ('Use for...'). Does not explicitly state when not to use it or compare to sibling tools like polymarket_edges, but the context signals show many siblings, and no exclusions are given. Still, clear usage context.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

compare_entitiesCompare EntitiesA
Read-onlyIdempotent
Inspect

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

ParametersJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnly, openWorld, idempotent, and non-destructive hints. The description adds behavioral details: data sources (SEC EDGAR/XBRL for companies, FAERS/FDA for drugs), sorting by primary metric, and return of citation URIs. No contradiction.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is information-dense but efficient. Every sentence adds value, though it is slightly long. It front-loads the core purpose and includes examples and instructions.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool's complexity (two entity types, multiple data fields), the description covers all essential aspects: input format, data retrieved, sorting, and return format (paired data + citation URIs). No output schema, but description compensates adequately.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% with descriptions for both parameters. The description enhances understanding by specifying allowed values (tickers/CIKs for company, drug names for drug) and explains sorting behavior. Examples are provided.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool performs side-by-side comparisons of 2-5 companies or drugs in a single parallel call, with specific example queries like 'compare X and Y' and 'rank these companies'. It distinguishes itself from sequential lookups.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It explicitly instructs to prefer this tool over sequential single-pack lookups when comparing entities. It provides context on when to use (comparison queries) and implies not for single entity lookup, with sibling entity_profile available.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

deep_researchDeep ResearchA
Read-onlyIdempotent
Inspect

ACCOUNT REQUIRED (free — sign in via GitHub at https://pipeworx.io/signup; depth:"thorough" needs a paid plan). If you are not signed in, use ask_pipeworx instead — it works on every tier. Grounded multi-source research across Pipeworx's 1455 STRUCTURED data sources (SEC filings, FRED/BLS economics, FDA, USPTO patents, markets, science, government records, etc.) in ONE call — this is NOT open-web search. Decomposes your question into focused facets, routes each to the right one of 5,529 tools IN PARALLEL, and returns a findings packet: verbatim evidence + confidence + source + fetched_at + a stable pipeworx:// citation per finding, with explicit gaps[] for facets the data couldn't answer (never invented). Best for broad/multi-part questions over structured data ("compare X and Y's regulatory + financial exposure", "research the filings + market picture for ACME"). For a single lookup use ask_pipeworx (one LLM call, not many). For BREAKING or colloquial CURRENT-NEWS / "what's the world saying about X" topics, prefer ask_pipeworx — it routes to live news APIs and the *-news-feeds packs; deep_research returns mostly empty gaps[] when the topic isn't in the structured catalog. Second-hop iteration: depth:"standard" re-angles unanswered gaps (gap recovery); depth:"thorough" additionally chases the best leads from the first pass — so multi-step questions resolve in one call. Every finding carries a hop field and a citation_uri — a resolvable pipeworx:// record URI, present only when the source emits one that resources/read can actually serve, so a citation you get back is always fetchable. "standard" and "thorough" also return contradictions[] flagging findings that disagree. Large records are semantically excerpted to the passages relevant to each facet (not head-truncated), so answers deep in a long filing/series aren't missed. Expect 15-60s (thorough with its follow-up + contradiction pass: up to ~90s).

ParametersJSON Schema
NameRequiredDescriptionDefault
depthNoHow many facets to research in parallel: quick=3 (single hop), standard=5 (default; adds a gap-recovery hop that re-angles unanswered facets + a contradictions[] scan across findings), thorough=8 (paid; adds a full iterative hop that chases leads + recovers gaps, plus the contradictions[] scan).
questionYesThe research question, in natural language. Broad/multi-part is fine — decomposition is the point.
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the annotations (readOnlyHint, openWorldHint, idempotentHint), the description richly discloses behaviors: decomposition into facets, parallel routing, gaps[] that are 'never invented', resolvable citation_uri, contradictions[] for deeper depths, semantic excerpting, expected latency (15-90s), and account tier requirements. It also notes that current-news topics will return mostly empty gaps[]. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Though long, every sentence earns its place by delivering operationally critical information: account requirements, what the tool does and does not do, when to avoid it, return structure, citation guarantees, and latency. Front-loaded with the account prerequisite, which is essential for call success. No fluff or repetition.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description fully compensates by explaining the return packet: verbatim evidence + confidence + source + fetched_at + citation_uri, plus gaps[] and contradictions[] as applicable. It also covers auth, fallback path, latency, and depth semantics. Given the tool's complexity and the absence of structured output metadata, this is a complete contextual picture.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% for both params, giving baseline 3. The description adds value beyond schema: it reveals that depth:'thorough' requires a paid plan, clarifies the depth levels' effect on gap-recovery hops and contradictions[], and notes that question can be broad/multi-part because decomposition is inherent. This contextualizes parameter choices without duplicating schema text.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with a precise verb+resource: 'Grounded multi-source research across Pipeworx's 1455 STRUCTURED data sources' and contrasts it with open-web search. It clearly distinguishes from siblings by naming ask_pipeworx as the single-lookup alternative, and explains the research workflow (decomposition, parallel routing, findings packet).

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly states when to use this tool: 'Best for broad/multi-part questions over structured data' with concrete examples. Provides clear exclusions: 'For a single lookup use ask_pipeworx' and 'For BREAKING or colloquial CURRENT-NEWS... prefer ask_pipeworx.' Also gives a fallback if not signed in: 'use ask_pipeworx instead — it works on every tier.'

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

discover_toolsDiscover ToolsA
Read-onlyIdempotent
Inspect

Find tools by describing the data or task. Use when you need to browse, search, look up, or discover what tools exist for: SEC filings, financials, revenue, profit, FDA drugs, adverse events, FRED economic data, Census demographics, BLS jobs/unemployment/inflation, ATTOM real estate, ClinicalTrials, USPTO patents, weather, news, crypto, stocks. Returns the top-N most relevant tools with names, descriptions, and full input schemas (with curated examples) — each result is ready to call directly, no second schema lookup needed. Call this FIRST when you have many tools available and want to see the option set (not just one answer).

ParametersJSON Schema
NameRequiredDescriptionDefault
qNoAlias for query.
taskNoAlias for query.
limitNoMaximum number of tools to return (default 20, max 50)
queryYesNatural language description of what you want to do (e.g., "analyze housing market trends", "look up FDA drug approvals", "find trade data between countries"). Accepts task, q, description, search as aliases.
searchNoAlias for query.
descriptionNoAlias for query.
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint=true, idempotentHint=true, destructiveHint=false. The description adds details about returning top-N relevant tools with full input schemas and curated examples, ready to call directly. No contradictions.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Description is informative but could be slightly more concise. However, each sentence adds value and it's well-structured with a clear front-load of purpose and usage.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given no output schema, the description explains it returns top-N tools with names, descriptions, and full input schemas with examples. Complete enough for a tool discovery tool.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema has 6 parameters with 100% description coverage, so baseline is 3. The description adds clarification about aliases (q, task, search, description) all mapping to 'query', and limit info. Adds some value beyond schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool finds tools by describing data or task, lists many example domains, and distinguishes from sibling tools (which are specific data tools). It's a discovery tool, not a data retrieval tool.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly says 'Use when you need to browse, search, look up, or discover what tools exist for ...' and 'Call this FIRST when you have many tools available and want to see the option set'. Clear guidance on when to use.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

entity_profileEntity ProfileA
Read-onlyIdempotent
Inspect

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO, news, GLEIF and returns: cik + company_name; recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. Pass ticker "AAPL" or zero-padded CIK "0000320193" — names not supported (use resolve_entity first if you only have a name).

ParametersJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type. Only "company" supported today; person/place coming soon.
valueYesTicker (e.g., "AAPL") or zero-padded CIK (e.g., "0000320193"). Names not supported — use resolve_entity first if you only have a name.
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already indicate readOnlyHint, openWorldHint, idempotentHint, and destructiveHint false. The description adds behavioral context: it fans out across multiple sources in parallel, soft-fails on patents due to sunset, and uses a GDELT→GNews fallback. It also lists the exact data returned. No contradictions with annotations. Slightly more detail on performance or caching would improve it.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is moderately concise with several sentences, but each earns its place by providing examples, guidance, and return structure. It front-loads the purpose with examples. Could be slightly more structured (e.g., bullet points), but it's efficient overall.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool has only 2 parameters, no output schema, and comprehensive annotations, the description thoroughly covers inputs, return fields (CIK, filings, fundamentals, patents, news, LEI), sources, and limitations (patents sunset, name restriction). It provides a complete picture for an agent to understand and use the tool correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so baseline is 3. The description adds semantic value by clarifying that 'value' accepts ticker or zero-padded CIK, and explicitly states that names are not supported (requiring a prior step). This reduces ambiguity beyond the schema's description.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description explicitly states it produces a 'full cross-source profile of a US public company in ONE parallel call' with example queries. It distinguishes from siblings by recommending it over chaining individual lookups, and its purpose is clearly differentiated from tools like 'compare_entities' or 'resolve_entity'.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives explicit guidance: 'ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view.' It also notes that names are not supported and advises to 'use resolve_entity first if you only have a name.' This clearly tells when and when not to use the tool.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

fda_application_historyFda Application HistoryA
Read-onlyIdempotent
Inspect

Retrieve one Drugs@FDA NDA, ANDA, or BLA application and return its products and chronological submission-action history. Submission codes require regulatory interpretation and do not by themselves establish approval scope, exclusivity, or current marketing.

ParametersJSON Schema
NameRequiredDescriptionDefault
application_numberYesNDA, ANDA, or BLA followed by digits.
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, openWorldHint, idempotentHint, and destructiveHint=false, covering safety. The description adds the caveat that submission codes require interpretation and don't establish approval scope/exclusivity/marketing, which is valuable behavioral context beyond annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Two sentences, purpose-first, with no wasted words. The regulatory caveat is useful and earns its place.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a one-parameter read-only tool with thorough annotations and no output schema, the description is sufficient. It explains what the tool returns and includes a critical interpretation warning, though it doesn't detail the return structure or pagination, which is acceptable given the lack of output schema.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The single parameter `application_number` is fully described in the schema with format 'NDA, ANDA, or BLA followed by digits.' The description repeats the application types but adds no additional syntax or semantics beyond the schema, so baseline 3 applies.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool retrieves a single Drugs@FDA application (NDA, ANDA, or BLA) and returns products plus chronological submission-action history. This distinguishes it from sibling tools like fda_drug_approvals or fda_crl_detail, which address different aspects.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines3/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives context about regulatory interpretation but does not explicitly state when to use this over alternatives or list exclusions. The use case is implied as retrieving application history, but no sibling alternatives are mentioned, so guidance is limited.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

fda_complete_response_lettersFda Complete Response LettersA
Read-onlyIdempotent
Inspect

Search FDA-disclosed Complete Response Letters for drug and biologic applications. Defaults to letter_type "COMPLETE RESPONSE"; optionally include other letter types in the same dataset. Returns the application’s current approval_status, letter metadata, an excerpt, and the official document URL.

ParametersJSON Schema
NameRequiredDescriptionDefault
skipNoPagination offset (default 0).
limitNoNumber of letters (1-100, default 20).
queryNoOptional full-text term or raw openFDA CRL search expression.
companyNoSponsor/company name.
to_dateNoOptional end date, YYYY-MM-DD.
from_dateNoOptional start date, YYYY-MM-DD.
application_numberNoNDA/BLA application number.
include_other_letter_typesNoInclude tentative approvals, rescissions, refusal-to-file letters, and other non-CRL records (default false).
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already indicate readOnly, openWorld, idempotent, and non-destructive behavior. The description adds value by specifying the exact return content (approval_status, letter metadata, excerpt, document URL) and the default filtering behavior, which goes beyond what annotations provide.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is a single, well-structured sentence that front-loads the action and resource, then lists key features. It contains no redundant words and efficiently conveys all necessary information.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Despite having no output schema, the description clearly states what is returned (approval_status, metadata, excerpt, URL). It also covers the default filtering and the optional inclusion of other letter types. For a search tool with 8 parameters, the description provides sufficient context for an agent to understand when and how to use it.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

All 8 parameters have descriptions in the schema (100% coverage), so the schema already documents each parameter's meaning. The description does not add further semantic detail beyond the schema, such as syntax examples or format constraints, so it does not improve parameter understanding. Baseline score of 3 is appropriate.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the action (search) and resource (FDA Complete Response Letters), and distinguishes it from sibling tools like fda_warning_letters or fda_drug_approvals by specifying the document type and default filtering. The verb 'Search' combined with the resource name makes the purpose unambiguous.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explains the default behavior (only COMPLETE RESPONSE type) and the option to include other letter types, which guides usage. However, it does not explicitly state when to use this tool versus the sibling fda_crl_detail tool (likely for individual letter details), missing an opportunity to clarify the choice between search and detail retrieval.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

fda_crl_detailFda Crl DetailA
Read-onlyIdempotent
Inspect

Retrieve one FDA Complete Response Letter by application number and optionally letter date. Returns the FDA-disclosed letter text and document URL. Confidential commercial and trade-secret material may be redacted by FDA.

ParametersJSON Schema
NameRequiredDescriptionDefault
letter_dateNoOptional exact letter date, YYYY-MM-DD, when an application has multiple CRLs.
application_numberYesRequired NDA/BLA application number.
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond annotations (readOnly, idempotent, non-destructive), the description discloses that it returns letter text and URL, and notes that confidential material may be redacted. This adds useful behavioral context without contradicting annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Three sentences, each informative: purpose, output, and caveat. Front-loaded with the core action, no unnecessary words.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a retrieval tool with 2 parameters and no output schema, the description covers what is returned (text, URL) and potential redaction. No gaps given the tool's complexity.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so parameters are fully described in the schema. The description adds minimal extra meaning beyond stating the two parameters and the purpose of letter_date for multiple CRLs, but does not enhance parameter understanding significantly.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a specific verb ('Retrieve') and resource ('one FDA Complete Response Letter') with clear parameters (application number, optionally letter date). It distinguishes from siblings like fda_complete_response_letters (plural) and other FDA tools by focusing on a single letter retrieval.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description clearly indicates when to use this tool (when you need a specific letter by application number). However, it does not explicitly mention when not to use it or point to alternatives, such as fda_complete_response_letters for listing.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

fda_drug_approvalsFda Drug ApprovalsA
Read-onlyIdempotent
Inspect

Find FDA-approved drugs by brand name, active ingredient, or application number. To find generic versions of a drug, search by active ingredient using products.active_ingredients.name (NOT openfda.generic_name — that field only works in the label endpoint). IMPORTANT: drug names in the FDA database are stored in UPPERCASE — always pass ingredient and brand names in uppercase (e.g. "APIXABAN" not "apixaban") or you will get 0 results. Returns approval status, sponsor, application number (ANDA = generic, NDA = brand), and application details. There is NO queryable "application_type" field — never add application_type:"ANDA" (it returns 0 results). To limit to generics, search by active ingredient and read the ANDA/NDA prefix on application_number in the results. This endpoint has NO indication/disease field — for "drugs approved to treat " use fda_drug_labels (which searches indications_and_usage); an indication phrase passed here is silently ignored and matches by drug name only.

ParametersJSON Schema
NameRequiredDescriptionDefault
limitNoNumber of results (1-100, default 10)
queryYesOpenFDA drugsfda search query. Drug names MUST be UPPERCASE in quotes. To find all generics for a drug: 'products.active_ingredients.name:"APIXABAN"' (returns all ANDA + NDA approvals). By brand: 'openfda.brand_name:"KEYTRUDA"'. By original submission: 'submissions.submission_type:"ORIG"'. Do NOT use application_type (no such field — returns 0); ANDA vs NDA is read from the application_number prefix in the results, not filtered in the query. NOTE: use products.active_ingredients.name (not openfda.generic_name which is a label-API field and returns 0 here).

Output Schema

ParametersJSON Schema
NameRequiredDescription
totalYesTotal count of matching FDA-approved drugs
resultsYesArray of drug approval objects
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint=true, idempotentHint=true, and destructiveHint=false. The description adds valuable behavioral traits beyond these: no indication field, no queryable application_type, uppercase requirement, and field behavior differences. These are not covered by annotations, so description adds meaningful context.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is somewhat lengthy but front-loaded with critical information (purpose, warnings, alternatives). Every sentence serves a purpose for correct usage, though it could be slightly more concise by combining related warnings. The structure prioritizes key constraints early.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool's complexity (query syntax, special fields, uppercase), the description covers all necessary context. It explains return values (approval status, sponsor, ANDA/NDA prefix) and warns about missing fields. The output schema exists but the description still adds value for result interpretation. It is complete for a complex query tool.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so baseline is 3. However, the description adds significant meaning beyond the schema: it explains query syntax, field differences, uppercase requirement, common pitfalls, and provides examples. The param descriptions in the schema are detailed, but the description's warnings and context (e.g., NOT using openfda.generic_name) compensate richly.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states it finds FDA-approved drugs by brand name, active ingredient, or application number. It uses specific verbs and resources, and distinguishes itself from siblings like fda_drug_labels by specifying that it lacks indication data.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description provides explicit guidance on when to use this tool versus alternatives (e.g., fda_drug_labels for conditions), warns about field selection (products.active_ingredients.name vs openfda.generic_name), requires uppercase input, and advises against using non-existent fields like application_type. It gives clear context and exclusions.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

fda_drug_eventsFda Drug EventsA
Read-onlyIdempotent
Inspect

Search FAERS adverse event reports by drug name, MedDRA reaction term, or date range. Returns report counts, reaction types, seriousness levels, and dates. Natural multi-word reaction phrasing is retried against MedDRA preferred-term word order before an empty result is reported. FAERS reports do not establish incidence or causality.

ParametersJSON Schema
NameRequiredDescriptionDefault
skipNoOffset for pagination (default 0)
limitNoNumber of results (1-100, default 10)
queryYesOpenFDA search query. Examples: 'patient.drug.openfda.brand_name:"OZEMPIC"', 'patient.drug.openfda.generic_name:"semaglutide"+AND+serious:1', 'receivedate:[20240101+TO+20241231]'

Output Schema

ParametersJSON Schema
NameRequiredDescription
skipYesOffset used in pagination
limitYesNumber of results returned
totalYesTotal count of matching adverse event reports
resultsYesArray of adverse event report objects
reaction_resolvedNoThe MedDRA preferred term actually used for the filter
reaction_requestedNoThe reaction term as the caller supplied it, uppercased
reaction_resolutionNoHow the supplied reaction term mapped onto a MedDRA preferred term. not_a_meddra_preferred_term means the filter matched nothing — counts are zero because the term missed, not because no reports exist
reaction_resolution_hintNoPresent when the term matched nothing; names a working way to discover the real preferred terms
reaction_resolution_noteNoPresent when word order was corrected; states the substitution made
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already cover read-only and non-destructive behavior. The description adds context about retry logic for natural multi-word reaction phrasing against MedDRA preferred-term order, and notes that FAERS reports do not establish incidence or causality. This goes beyond the annotation-provided safety profile.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is three sentences, front-loaded with the primary action and scope. Each sentence adds value, including the retry caveat and data limitation. No filler.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the high schema coverage, annotations, and presence of an output schema, the description sufficiently covers the tool's purpose and behavior. It could potentially mention how it relates to more specialized FAERS tools, but that is not necessary for basic invocation.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%, so the schema fully documents all three parameters. The description adds no additional parameter-level detail beyond restating search facets. Baseline 3 is appropriate.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool searches FAERS adverse event reports by drug name, MedDRA reaction term, or date range, and lists what it returns. This specific verb-resource pairing distinguishes it from sibling tools like fda_faers_trend or fda_event_counts.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description provides clear context on when to use the tool: searching FAERS reports by drug, reaction, or date range. It does not explicitly exclude alternatives or mention when not to use it, but the search scope is well-defined.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

fda_drug_labelsFda Drug LabelsA
Read-onlyIdempotent
Inspect

Get FDA drug labeling (SPL) by drug name OR by INDICATION. This is the tool for "what drugs are approved to treat " — it searches the indications_and_usage text, which the drugsfda approvals endpoint does NOT carry. Query by brand/generic name (openfda.brand_name:"HUMIRA"), or by indicated use (indications_and_usage:"rheumatoid arthritis"). Returns indications, boxed/other warnings, dosage, contraindications, and adverse reactions (each text field capped, set_id preserved for out-of-band full-label fetch). Note: FDA label publication trails approval by weeks, so a just-approved drug may not have a label yet.

ParametersJSON Schema
NameRequiredDescriptionDefault
limitNoNumber of results (1-100, default 5)
queryYesOpenFDA search query. Examples: 'openfda.brand_name:"HUMIRA"', 'openfda.generic_name:"adalimumab"'

Output Schema

ParametersJSON Schema
NameRequiredDescription
totalYesTotal count of matching drug labels
resultsYesArray of drug label objects
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare safe read operation. Description adds valuable context: text fields are capped, set_id preserved for full-label retrieval, and warning about delayed label publication. No contradictions.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Front-loaded with core purpose, each subsequent sentence adds critical detail (contrast with sibling, query formats, return fields, caveat). No filler; every sentence earns its place.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With output schema present (likely detailed), description covers returned fields, limits, and an important temporal caveat. Complete for a read-only search tool with rich annotations.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema has 100% coverage, so baseline 3. Description adds meaning by explaining query parameter syntax with examples (e.g., 'openfda.brand_name:"HUMIRA"', 'indications_and_usage:"rheumatoid arthritis"'), and specifies limit defaults to 5. Adds value beyond schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

Description clearly states it retrieves FDA drug labeling by drug name or indication, distinguishes from sibling tool fda_drug_approvals by noting that approvals endpoint lacks indications text, and lists returned content (indications, warnings, dosage, etc.). Verb+resource specific and contrasts with alternatives.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly frames the tool as the one to use for 'what drugs are approved to treat <condition>', contrasts with fda_drug_approvals, provides query examples, and notes limitation of label publication lag. Clear when to use and when not.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

fda_drug_recallsFda Drug RecallsA
Read-onlyIdempotent
Inspect

Search FDA drug recalls and enforcement actions by drug name or reason — returns recall classification, date, reason and enforcement status. A multi-word search is tried as ALL terms first and falls back to ANY term when nothing matches all of them; the response says which happened in match_mode, so a loose match is never mistaken for a precise one. Recall reasons are free narrative text and often name the contaminant rather than the harm ("NDMA impurity", not "cancer"), so search the substance when a symptom finds nothing.

ParametersJSON Schema
NameRequiredDescriptionDefault
limitNoNumber of results (1-100, default 10)
queryYesOpenFDA search query. Examples: 'openfda.brand_name:"VALSARTAN"', 'classification:"Class I"', 'reason_for_recall:"contamination"'

Output Schema

ParametersJSON Schema
NameRequiredDescription
totalYesTotal count of matching drug recalls
resultsYesArray of drug recall/enforcement objects
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the readOnly/openWorld/idempotent annotations, the description discloses important behavioral details: the multi-word fallback from ALL to ANY matching, the match_mode indicator in the response, and the free-text nature of recall reasons. These additions materially help the agent interpret results and avoid mistaking loose matches for precise ones.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is three sentences with no wasted words. The primary purpose and return values are front-loaded, followed by crucial behavioral caveats and domain-specific search advice. Every sentence earns its place.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool's moderate complexity, the description covers purpose, return fields, match behavior, and query strategy. The output schema handles return values, and annotations cover safety. No critical gaps remain for an agent to use the tool effectively.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The input schema already covers both parameters with 100% coverage, so the baseline is 3. The description adds helpful guidance on query interpretation (e.g., free-text reasons, substance vs. symptom search) but does not add new parameter-level syntax or semantics beyond what the schema provides.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states a specific verb ('Search') and resource ('FDA drug recalls and enforcement actions'), and lists the returned fields (classification, date, reason, enforcement status). It distinguishes from sibling tools by specifying 'drug' recalls, differentiating from fda_food_recalls.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives clear context for when to use the tool (searching drug recalls) and includes useful search-strategy guidance, such as using ALL terms with fallback to ANY and searching for the substance name when a symptom finds nothing. However, it does not explicitly name alternatives or exclusions, so it stops short of a 5.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

fda_drug_shortagesFda Drug ShortagesA
Read-onlyIdempotent
Inspect

Search the FDA Drug Shortages database by generic or brand name, manufacturer, status, or an advanced openFDA query. Returns national supply records and available FDA dates; reason and other details are sparse in the upstream data. This is not local pharmacy inventory or medical advice.

ParametersJSON Schema
NameRequiredDescriptionDefault
drugNoGeneric or proprietary drug name, e.g. "lisdexamfetamine".
skipNoPagination offset (default 0).
limitNoNumber of records (1-100, default 20).
queryNoOptional raw openFDA shortage query for advanced filters. Combined with the structured filters using AND.
statusNoFDA status filter: "Current", "Resolved", or "To Be Discontinued".
manufacturerNoCompany/manufacturer name.
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, openWorldHint, idempotentHint, and destructiveHint. The description adds valuable context: it warns about sparse upstream data and clarifies it is not real-time local inventory. This goes beyond annotations to set realistic expectations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is two sentences with no unnecessary words. The first sentence states the core function and search methods; the second clarifies return data and disclaimers. It is front-loaded and every sentence earns its place.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given no output schema, the description adequately explains return values ('national supply records and available FDA dates') and notes data sparseness. It does not detail pagination or exact date fields, but for a search tool with comprehensive schema and annotations, this is sufficient.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% with descriptive parameter descriptions. The description summarizes the filters ('by generic or brand name, manufacturer, status, or an advanced openFDA query') but does not add new meaning beyond the schema. Baseline of 3 is appropriate.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description explicitly states it searches the FDA Drug Shortages database by various criteria, names the return type (national supply records), and clearly distinguishes itself from local pharmacy inventory or medical advice. The verb 'Search' and resource are specific, making the purpose immediately clear.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines3/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description provides a clear when-not-to-use directive ('not local pharmacy inventory or medical advice') and notes data sparseness. However, it does not compare this tool to siblings like fda_shortage_changes or fda_drug_approvals, leaving the agent to infer when to choose this tool over alternatives.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

fda_event_countsFda Event CountsA
Read-onlyIdempotent
Inspect

Aggregate adverse events by reaction type, patient age, or outcome. Returns top reactions for a drug and event trends over time.

ParametersJSON Schema
NameRequiredDescriptionDefault
queryYesOpenFDA search query to filter events before counting. Same syntax as fda_drug_events.
count_fieldYesField to count/aggregate by. Examples: "patient.reaction.reactionmeddrapt.exact" (top reactions), "receivedate" (timeline), "serious" (severity breakdown), "patient.drug.openfda.brand_name.exact" (co-reported drugs)

Output Schema

ParametersJSON Schema
NameRequiredDescription
queryYesThe search query used to filter events
resultsYesArray of count results by term
count_fieldYesThe field aggregated/counted by
requested_queryNoThe search query as supplied, when it differs from the resolved query in `query`
reaction_resolvedNoThe MedDRA preferred term actually used for the filter
reaction_requestedNoThe reaction term as the caller supplied it, uppercased
reaction_resolutionNoHow the supplied reaction term mapped onto a MedDRA preferred term. not_a_meddra_preferred_term means the filter matched nothing — counts are zero because the term missed, not because no reports exist
reaction_resolution_hintNoPresent when the term matched nothing; names a working way to discover the real preferred terms
reaction_resolution_noteNoPresent when word order was corrected; states the substitution made
Behavior3/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, idempotentHint, and destructiveHint false, covering safety. The description adds output context (top reactions, event trends) but does not disclose limits, pagination, or other behavioral traits. For a tool with strong annotations, a 3 is appropriate.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is two sentences, front-loaded with the action, and every word contributes to understanding. No filler or redundancy.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

The description, combined with a comprehensive schema and output schema, covers the essential aspects of the tool well. It lacks explicit sibling differentiation, but given the rich structured data and annotations, it is sufficiently complete.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, with both query and count_field fully described. The description's mention of 'reaction type, patient age, or outcome' merely restates examples already in the schema, adding no extra semantic value. Baseline 3 applies.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose4/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states a specific action ('Aggregate adverse events') and resource ('by reaction type, patient age, or outcome'), and mentions return types. However, it does not explicitly distinguish from sibling tools like fda_faers_reaction_profile or fda_faers_trend, so it falls short of a 5.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines3/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description implies usage for aggregation/counting but provides no explicit when-to-use or alternatives. The schema reference to 'Same syntax as fda_drug_events' is a pointer, but the description itself lacks guidance on selecting this tool over similar ones.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

fda_faers_reaction_profileFda Faers Reaction ProfileA
Read-onlyIdempotent
Inspect

Summarize the most frequently co-reported FAERS reactions plus serious/non-serious report counts for a drug. Counts are spontaneous reports with duplicates, co-medications, and reporting bias—not event rates or proof of causation.

ParametersJSON Schema
NameRequiredDescriptionDefault
drugYes
limitNo
to_dateNo
from_dateNo
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already establish read-only, idempotent, non-destructive behavior. The description adds important caveats that counts include duplicates, co-medications, and reporting bias, and are not event rates or proof of causation. This goes beyond annotations by clarifying data interpretation. It does not describe return format, but the caveat is significant.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is two sentences with no filler. The first sentence states the core function, the second adds a necessary caveat. Both earn their place, and it is front-loaded.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness3/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

The description covers the main output (reactions and counts) and a crucial caveat, but lacks parameter details and return structure. Given the absence of an output schema and 0% schema coverage, this is a noticeable gap. It is adequate for a high-level understanding but not fully complete for invocation.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters2/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 0%, and the description does not explain the four parameters (drug, limit, to_date, from_date) beyond their self-evident names. The dates and limit semantics are left unspecified, such as date format or default behavior. With such low schema coverage, the description should compensate but does not.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool's function: summarizing frequently co-reported FAERS reactions plus serious/non-serious report counts for a drug. The verb 'summarize' and specific resource ('FAERS reactions') make the purpose unambiguous. It distinguishes from siblings by focusing on reaction profile rather than signals or trends.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines3/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description implies use for a drug's reaction profile but does not explicitly say when to use this tool over siblings like fda_faers_signal_summary or fda_faers_trend. It provides context about the data (spontaneous reports) but no explicit alternatives or exclusions. This is implied usage without direct guidance.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

fda_faers_signal_summaryFda Faers Signal SummaryA
Read-onlyIdempotent
Inspect

Calculate report-level FAERS disproportionality routing metrics for one drug/reaction pair using a 2×2 reporting table. The reaction argument matches one whole MedDRA preferred term, so a broad word like "neuropathy" counts only reports filed under that exact term and not the specific terms containing it. Natural multi-word phrasing is resolved to MedDRA word order and disclosed; a term matching nothing is reported as unresolved rather than as zero reports. ROR/PRR are screening statistics—not incidence, causality, comparative drug safety, or an FDA safety conclusion.

ParametersJSON Schema
NameRequiredDescriptionDefault
drugYesBrand or generic drug name.
to_dateNoOptional YYYY-MM-DD.
reactionYesMedDRA preferred term, matched whole rather than as a substring. Natural English word order is accepted and corrected ("ischaemic optic neuropathy" resolves to "OPTIC ISCHAEMIC NEUROPATHY").
from_dateNoOptional YYYY-MM-DD.
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the annotations (readOnly, idempotent, openWorld), the description discloses several important behaviors: whole-term matching only, natural word order resolution and disclosure, unresolved terms reported as unresolved rather than zero, and the screening-statistic nature of ROR/PRR. This adds substantial context beyond the structured fields.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is concise (three sentences) and front-loaded: it starts with the core calculation, then adds matching nuance, then statistical caveats. Every sentence earns its place with no filler.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a tool without an output schema, the description covers the purpose, matching behavior, and interpretation boundaries well. It could explicitly state the return format (e.g., a table with ROR/PRR values), but the description is largely complete for an analysis tool with robust annotations.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so the schema already documents all parameters. The description adds meaningful detail by explaining the neuropathy example for whole-term matching and the unresolved-not-zero behavior, which enriches the reaction parameter semantics beyond the schema text.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with a specific verb and resource: 'Calculate report-level FAERS disproportionality routing metrics for one drug/reaction pair using a 2×2 reporting table.' This clearly distinguishes the tool from sibling FDA tools like fda_faers_reaction_profile by emphasizing a single pair and the 2×2 table methodology.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description provides clear context for when to use this tool: it is for a single drug/reaction pair and requires exact MedDRA term matching, with explicit notes on how broad words like 'neuropathy' are handled. It also clarifies statistical limitations (not incidence/causality/safety conclusion), which helps rule out inappropriate use, though it does not name specific alternative tools.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

fda_faers_trendFda Faers TrendA
Read-onlyIdempotent
Inspect

Aggregate daily FAERS report counts into calendar months for a drug and optional reaction over a bounded date window. The reaction argument matches one whole MedDRA preferred term, so a broad word like "neuropathy" counts only reports filed under that exact term and not the specific terms containing it. Natural multi-word phrasing is resolved to MedDRA word order and disclosed; a term matching nothing is reported as unresolved rather than as zero reports. Trends reflect reporting activity, publicity, utilization, duplicates, and database updates—not incidence or changing clinical risk.

ParametersJSON Schema
NameRequiredDescriptionDefault
drugYes
to_dateYes
reactionNo
from_dateYes
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the readOnly/no-destructive annotations, the description discloses specific behavioral subtleties: exact MedDRA preferred term matching, natural multi-word phrase resolution, unresolved terms reported as unresolved rather than zero, and the caveat that trends reflect reporting activity, publicity, utilization, duplicates, and database updates. This is rich, non-obvious context that significantly aids the agent.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is three sentences, front-loaded with the core purpose, and every subsequent clause adds necessary nuance about reaction matching or interpretation. It is appropriately sized for the tool's complexity without any wasted words.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

The description covers the tool's purpose, reaction behavior, and interpretation caveats thoroughly. Since there is no output schema, it does not fully explain the return structure, but 'aggregate into calendar months' conveys the expected form. It is adequate for a read-only aggregate tool with strong annotations.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

With 0% schema description coverage, the description must compensate. It identifies drug, optional reaction, and a bounded date window (implying from_date/to_date), and thoroughly explains reaction matching semantics. However, it omits details about drug matching (e.g., brand name vs generic) and date format, leaving required parameters only partially clarified.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states 'Aggregate daily FAERS report counts into calendar months for a drug and optional reaction over a bounded date window,' clearly specifying verb, resource, and scope. It distinguishes itself from sibling tools like fda_event_counts or fda_faers_reaction_profile by emphasizing the monthly aggregation and optional reaction filter.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It gives clear context: use for monthly trends, with an optional reaction, and cautions that trends reflect reporting activity, not incidence or clinical risk. However, it does not explicitly name alternatives or state situations where this tool should not be used, so it stops short of full exclusionary guidance.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

fda_food_recallsFda Food RecallsA
Read-onlyIdempotent
Inspect

Search FDA FOOD recall / enforcement reports (openFDA /food/enforcement) — product recalls, reasons, classification, recalling firm, distribution, and status. Use for food-safety / recall-history questions (distinct from fda_drug_recalls which covers drugs).

ParametersJSON Schema
NameRequiredDescriptionDefault
limitNoNumber of results (1-100, default 10)
queryNoOpenFDA search query (optional — omit for most recent recalls). Examples: 'reason_for_recall:"Listeria"', 'state:"CA"', 'classification:"Class I"'.
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already indicate readOnly and idempotent. The description adds that it queries openFDA /food/enforcement and details return fields (reasons, classification, etc.), offering useful behavioral context beyond annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Two concise sentences, front-loaded with the action, no wasted words.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a simple read-only tool with well-documented parameters, annotations, and no output schema, the description sufficiently covers purpose, scope, and usage differentiation.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% with descriptions and examples. The description adds minimal extra meaning; it mentions 'optional — omit for most recent recalls' which is already in schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states it searches FDA food recall enforcement reports, listing specific fields (product recalls, reasons, classification, etc.), and explicitly distinguishes from sibling fda_drug_recalls.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It advises use for food-safety/recall-history questions and differentiates from fda_drug_recalls, providing clear context. However, it could be more explicit about when not to use it.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

fda_novel_approvalsFda Novel ApprovalsA
Read-onlyIdempotent
Inspect

Most recent novel drug approvals — the newest drugs approved by the FDA. Use for "what is the most recent novel drug the FDA approved", "latest FDA drug approvals", "recently approved new drugs or biologics this month/year". Returns original NDA/BLA approvals (generics excluded by default) sorted newest-first, with approval date, brand name, active ingredients, sponsor, and application number. Not for label text (fda_drug_labels) or searching a specific known drug (fda_drug_approvals).

ParametersJSON Schema
NameRequiredDescriptionDefault
daysNoLook-back window in days (1-365, default 90)
limitNoMax approvals to return (1-50, default 10)
include_genericsNoAlso include original ANDA (generic) approvals (default false — novel means NDA/BLA only)
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, idempotentHint, and non-destructive behavior. The description adds transparency by stating that generics are excluded by default and results are sorted newest-first, which goes beyond the annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is concise with no redundant sentences. It starts with the core purpose, then gives usage examples, and ends with return fields and exclusions. Every sentence adds value.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given no output schema, the description adequately specifies the return fields. It covers purpose, usage, and behavioral nuances. However, it does not mention pagination or rate limits, which are minor omissions for a simple list tool.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% with clear descriptions for all 3 parameters. The description does not add additional parameter information beyond what the schema provides, except for reaffirming the default exclusion of generics. Baseline 3 is appropriate.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states it returns the most recent novel drug approvals (NDA/BLA) with specific fields, and distinguishes itself from sibling tools fda_drug_labels and fda_drug_approvals by explicitly stating what it is not for.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description provides explicit usage examples ('what is the most recent novel drug the FDA approved', 'latest FDA drug approvals') and excludes cases ('Not for label text (fda_drug_labels) or searching a specific known drug (fda_drug_approvals)').

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

fda_postmarket_risk_profileFda Postmarket Risk ProfileA
Read-onlyIdempotent
Inspect

Combine a drug’s FAERS reporting profile, label warning fields, and FDA recall records for review routing. This is not a validated safety comparison, causal assessment, incidence estimate, or substitute for FDA communications and clinical review.

ParametersJSON Schema
NameRequiredDescriptionDefault
drugYes
to_dateNo
from_dateNo
recall_limitNo
reaction_limitNo
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, openWorldHint, idempotentHint, and destructiveHint=false. The description adds meaningful context by naming the combined data sources and warning that the output is not a validated safety assessment, which goes beyond the annotations and helps manage expectations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is composed of two concise sentences: the first states the action and purpose, the second adds essential caveats. There is no redundant wording or unnecessary detail.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness3/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

There is no output schema, and the description does not cover parameter details or output format. It provides a strong high-level purpose and limitations, but agents need more information about date ranges and limits to use the tool effectively, especially given the parameter count of 5.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters1/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 0%, and the description does not explain any of the five parameters. While 'drug' is implied, to_date, from_date, recall_limit, and reaction_limit are left undefined, leaving the agent without semantic guidance for required inputs.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool's function: combining a drug's FAERS reporting profile, label warning fields, and FDA recall records for review routing. This distinguishes it from sibling tools like fda_faers_reaction_profile, fda_drug_labels, and fda_drug_recalls, which focus on individual data sources.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description identifies the intended context ('for review routing') and explicitly lists what it is not for (validated safety comparison, causal assessment, etc.), providing clear when-not guidance. It does not name alternative tools for those cases, so it falls short of a 5.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

fda_shortage_changesFda Shortage ChangesA
Read-onlyIdempotent
Inspect

FDA drug-shortage records ordered by update_date, newest first, then restricted to the requested look-back window. Use for recently updated, discontinued, or resolved national shortages; this does not imply availability at any specific pharmacy or hospital.

ParametersJSON Schema
NameRequiredDescriptionDefault
daysNoLook-back window in days (1-365, default 30).
limitNoMaximum records to return (1-100, default 25).
statusNoOptional FDA status: "Current", "Resolved", or "To Be Discontinued".
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already indicate readOnly, openWorld, idempotent, and non-destructive. The description adds specific behavioral details: ordering by update_date, newest-first, and restriction to a look-back window. The caveat about pharmacy availability also provides helpful transparency beyond annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Two sentences that are concise and front-loaded: the first sentence states the core functionality, the second provides usage guidance and a caveat. Every word earns its place.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a read-only, filtered-list tool with good annotations, the description covers purpose, ordering, filtering, and a crucial limitation. Lack of output schema is somewhat mitigated by the simple nature of the tool. A brief note on return fields would make it fully complete, but it's adequate.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Input schema has 100% coverage with descriptions for days, limit, and status. The description mentions 'look-back window' and 'optional status' but adds little beyond the schema. With full schema coverage, a score of 3 is appropriate as the description does not enhance parameter understanding significantly.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

Description clearly states it returns FDA drug-shortage records ordered by update_date, newest first, restricted to a look-back window. It specifies the use case (recently updated, discontinued, or resolved national shortages) and distinguishes from sibling tools like fda_drug_shortages which likely lack date ordering.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly states 'Use for recently updated, discontinued, or resolved national shortages' and includes a caveat about availability. However, it does not directly mention when not to use this tool or explicitly name alternatives (e.g., fda_drug_shortages for unfiltered lists), which would further clarify selection.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

fda_warning_lettersFda Warning LettersA
Read-onlyIdempotent
Inspect

Search FDA WARNING LETTERS — official enforcement letters FDA sends firms for violations (CGMP, adulterated/misbranded products, unapproved claims). Answers "FDA warning letters for ", "recent FDA warning letters about supplements/devices". Full-text search over ~3,600 letters (company names, subjects, products). Returns each letter's company, posted/issued dates, issuing FDA office, subject, and a link to the full letter text. Keyless, live from fda.gov.

ParametersJSON Schema
NameRequiredDescriptionDefault
limitNoMax letters to return, 1–50 (default 10). Newest first.
searchNoFull-text search — a company name (e.g. "Blooming"), product ("supplement"), or violation topic ("CGMP"). Omit for the most recent letters.
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already indicate readOnly, openWorld, idempotent, non-destructive. Description adds context about types of violations (CGMP, adulterated, unapproved claims), data source (fda.gov, keyless live data), and output components. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Two concise sentences and a return-field list. Every sentence adds value, no redundant information. Front-loaded with purpose and examples.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With 2 parameters, no output schema, and safety annotations, the description fully covers how to use the tool, what results contain, and data provenance. No gaps.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% with descriptions for both parameters. Description adds examples and clarifies search scope (company, product, violation topic) and default behavior (omit for recent letters). Adds meaningful context beyond schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

Description clearly states it searches FDA Warning Letters, explains what they are (enforcement letters for violations), provides example queries, and lists return fields. Distinct from siblings like fda_drug_approvals or fda_food_recalls.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Provides explicit query examples ('FDA warning letters for <company>', 'recent FDA warning letters about supplements/devices') and notes to omit search for most recent letters. Does not explicitly mention alternative tools but context is clear.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

forgetForgetA
DestructiveIdempotent
Inspect

Delete a previously stored memory by key. Use when context is stale, the task is done, or you want to clear sensitive data the agent saved earlier. Pair with remember and recall.

ParametersJSON Schema
NameRequiredDescriptionDefault
keyYesMemory key to delete
Behavior3/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare destructiveHint=true and idempotentHint=true, so the description adds minimal behavioral insight beyond 'delete'. No contradiction, but no added value.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Two efficient sentences covering purpose, usage context, and sibling references with zero fluff.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Sufficient for a simple destructive but idempotent tool with good annotations. Could mention idempotent behavior, but not critical.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% with a clear description of the 'key' parameter. The tool description does not add extra semantic meaning beyond what the schema provides.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states 'Delete a previously stored memory by key' with a specific verb and resource. It also references sibling tools 'remember and recall', distinguishing itself as the deletion counterpart.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly states when to use: 'when context is stale, the task is done, or you want to clear sensitive data'. It also advises pairing with 'remember and recall', providing clear alternatives.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

generate_llms_txtGenerate llms.txtA
Read-onlyIdempotent
Inspect

Generate a production-ready llms.txt file for any URL so AI crawlers (ChatGPT, Claude, Perplexity) can index the site cleanly. Fetches the page, extracts title/description/key links, and emits the standard llms.txt markdown format. Output is a single text blob ready to drop at site-root/llms.txt. Useful for: getting a client's site indexed by AI, drafting llms.txt for your own project, or auditing how an AI crawler would see a competitor.

ParametersJSON Schema
NameRequiredDescriptionDefault
urlYesFull URL of the site to summarize, e.g. "https://example.com" or a specific landing page.
max_linksNoMaximum number of link entries to include (default 25, max 50).
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The description goes beyond annotations by detailing the process: fetches the page, extracts title/description/key links, and emits standard markdown format. It also states the output is a single text blob ready for placement, providing rich behavioral context.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is concise with three front-loaded sentences covering purpose, output format, and use cases. No wasted words; every sentence adds value.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the rich annotations and schema, the description provides sufficient context: what the tool does, how it works, output format, and use cases. Minor omissions like error handling or invalid URL handling do not detract significantly from completeness.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100% for both parameters (url and max_links). The description does not add extra semantics beyond what the schema already provides, so baseline score of 3 is appropriate.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool generates a production-ready llms.txt file for any URL, specifying the verb 'generate', the resource 'llms.txt file', and the context 'for any URL'. It distinguishes itself from sibling tools which are mostly FDA-specific or unrelated.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly lists use cases: getting a client's site indexed, drafting for own project, auditing competitor. It provides clear context for when to use the tool, though does not explicitly state when not to use it or alternatives, which is acceptable given no similar sibling tools.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

list_subscriptionsList SubscriptionsA
Read-onlyIdempotent
Inspect

List the caller's active subscriptions. Returns id, type, params, created_at, last_fired_at, fire_count for each. Use this to review what you're monitoring before adding more or to find an id to cancel.

ParametersJSON Schema
NameRequiredDescriptionDefault
include_inactiveNoInclude cancelled subscriptions in the response (default false).
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, idempotentHint, etc. The description adds that it lists active subscriptions by default and returns specific fields, which is useful context beyond annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is two efficient sentences: first states action and output, second provides usage guidance. No redundant information.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a simple listing tool with no output schema, the description sufficiently covers return fields and typical usage. It could mention pagination or limits, but the tool appears unbounded.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%; the parameter include_inactive is described in the schema. The description implicitly relates to this by mentioning 'active subscriptions', adding marginal value.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool lists the caller's active subscriptions and specifies the returned fields (id, type, etc.). It distinguishes from siblings like subscribe and unsubscribe by mentioning review and id retrieval.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly advises when to use the tool: 'Use this to review what you're monitoring before adding more or to find an id to cancel.' This guides the agent on appropriate invocation contexts.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

pipeworx_feedbackSend Pipeworx FeedbackAInspect

Tell the Pipeworx team something is broken, missing, or needs to exist. Use when a tool returns wrong/stale data (bug), when a tool you wish existed isn't in the catalog (feature/data_gap), or when something worked surprisingly well (praise). ONLY for tools served by this Pipeworx connection — if the tool came from a different MCP server in your client (another vendor's Gmail, Splunk, Slack, etc. connector), we cannot fix it and reporting it here only delays you; file it with that server instead. Not sure? Pipeworx tool names are the ones this connection lists. Describe the issue in terms of Pipeworx tools/packs — don't paste the end-user's prompt. Filing without an account returns a claim_token; pass it back later as pipeworx_feedback({claim_token:"pwfb_…"}) to read whether it was fixed and what changed. The team reads digests daily and signal directly affects roadmap. Rate-limited to 5 per identifier per day. Free; doesn't count against your tool-call quota.

ParametersJSON Schema
NameRequiredDescriptionDefault
typeNobug = something broke or returned wrong data. feature = a new tool or capability you wish existed. data_gap = data Pipeworx does not currently expose. praise = positive note. other = anything else.
contextNoOptional structured context: which tool, pack, or vertical this relates to.
messageNoYour feedback in plain text. Be specific (which tool, what error, what data was missing). 1-2 sentences typical, 2000 chars max.
claim_tokenNoRead the reply to a report you filed earlier: pass the `pwfb_…` token that filing returned, with no other arguments. Returns the status and, once resolved, what actually changed.
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the annotations (all false), the description discloses several valuable behaviors: filing without an account returns a claim_token, the token can be passed back later to read resolution status, the tool is rate-limited to 5 per identifier per day, and it is free and doesn't count against quota. These are non-obvious behaviors the annotations do not convey.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is longer than average, but every sentence earns its place: it defines the tool, provides use/non-use cases, gives content guidance, explains the token flow, and mentions limits. It is front-loaded with the core purpose and structured logically, with no redundant filler.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool has no output schema, the description covers the return token behavior and later status reading. It also covers rate limits, quota impact, and the team's response cadence. For a feedback tool with multiple edge cases and a two-phase claim-token flow, this is fully complete.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% and each parameter already has a description, so the baseline is 3. The description adds semantic guidance by telling the user to describe issues in terms of Pipeworx tools/packs, not to paste end-user prompts, and clarifies the claim_token round-trip workflow. This is a meaningful value-add over the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description names a specific verb+resource ('Tell the Pipeworx team') and enumerates the exact kinds of feedback (bug, feature/data_gap, praise). It clearly distinguishes from sibling tools by scoping to 'tools served by this Pipeworx connection' and even warns against filing for other MCP servers.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It gives explicit when-to-use triggers: wrong/stale data, missing tools or data, praise. It also gives an explicit when-not-to-use with a redirect: if the tool came from a different MCP server, file with that server. This is exactly the kind of decision guidance agents need.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

polymarket_arbitragePolymarket ArbitrageA
Read-onlyIdempotent
Inspect

Find arbitrage opportunities on Polymarket via monotonicity violations + partition-sum checks. Call with NO args for a trending_scan of the top ~200 markets by weekly volume; pass event for the strongest per-event partition_check, or topic for a themed cross-event scan. event (recommended for a specific market): pass a Polymarket event slug like "fed-decision-may-2026" or "when-will-bitcoin-hit-150k"; walks child markets, checks date-axis / threshold-axis ordering AND computes the partition_check (sum of YES prices across mutually-exclusive legs — should ≈1; deviations >3pp emit a BUY/SELL EVERY LEG signal). topic (for cross-event scanning): pass a seed question like "Strait of Hormuz traffic returns to normal" or "Fed rate decision"; searches related events across the platform, flattens markets, runs the comparator on the union. Cross-event mode catches "...by May 31" vs "...by Jun 30" patterns that single-event misses. SEMANTIC ANCHOR: cross-event pairs require ≥0.30 Jaccard similarity on question tokens (prevents Powell-Fed-Pause being paired with Powell-DOJ-probe); skipped_low_similarity surfaces the rejected pair count. PARTITION FILTER: drops will-person-X / will-manager-Y / will-someone-else- placeholder slugs; partitions with >20% placeholder fraction return null arb signal. Response: opportunities[] (gap_pp, suggested_trade, reasoning, monotonicity violation context), and in event mode partition_check{sum_yes_prices, gap_from_1, placeholders_filtered, suggested_trade}. FILL CHECK: when the partition signal fires, arbitrage.fill_check prices it against live CLOB depth (theoretical_edge_pp_at_book vs realizable_edge_pp at 1000 shares/leg, thin_legs[]) — realizable_edge_pp ≤ 0 means the overround exists only at last-trade, not in the book; do not trade it. For custom sizing use polymarket_fill_risk.

ParametersJSON Schema
NameRequiredDescriptionDefault
eventNoSingle-event mode (use this if you know the specific Polymarket event): event slug like "fed-decision-may-2026" or "when-will-bitcoin-hit-150k". Full Polymarket URLs also accepted.
topicNoCross-event mode (use this if you want to scan related events across the platform): a topic or seed question like "Fed rate decision" or "Strait of Hormuz traffic returns to normal". Tool searches Polymarket for related events and checks monotonicity across them.
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations declare readOnlyHint, openWorldHint, idempotentHint, and non-destructive; description adds rich detail on internal logic (monotonicity, partition checks, semantic anchor, partition filter, fill check), response structure, and caution about unrealizable edges. No contradiction.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Well-structured with clear sections (SEMANTIC ANCHOR, PARTITION FILTER, FILL CHECK), front-loaded with main purpose. While lengthy, each sentence adds distinct value; minor verbosity but appropriate for complexity.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

No output schema, but description fully explains response fields (opportunities[], partition_check, fill_check details). Covers edge cases (placeholders, low similarity, unrealizable edge) and gives sufficient context for a complex arbitrage tool.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema has 100% coverage with descriptions; description adds examples ('fed-decision-may-2026', 'Fed rate decision') and explains each mode's behavior in depth (walking child markets, computing partition_check, searching related events), far exceeding schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool finds arbitrage opportunities via monotonicity violations and partition-sum checks. It distinguishes modes (no args, event, topic) and verbs like 'Find' and 'scan', and differs from siblings like polymarket_edges or polymarket_fill_risk.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly tells when to use each mode: no args for trending scan, event for specific market, topic for cross-event scanning. Recommends event mode and explains cross-event mode catches missed patterns. Also references polymarket_fill_risk for custom sizing, providing an alternative.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

polymarket_edgesPolymarket EdgesA
Read-onlyIdempotent
Inspect

Scan top Polymarket markets and return opportunities where Pipeworx data disagrees with market price. Built for "what should I bet on today" — agents discover opportunities without paging hundreds of markets. FIVE MODEL FAMILIES grouped into three response segments under by_segment: (1) MODEL_DRIVEN — crypto_price (lognormal barrier from 90d FRED log-returns) and news_momentum (GDELT 7d/21d article-volume ratio, soft signal w/ halved Kelly). (2) STRUCTURAL_ARBITRAGE — partition_overround on mutually-exclusive events; per-leg favorite-longshot bias correction with per-sport α (tennis 1.02, soccer 1.10, MMA 1.15, default 1.0); placeholder-slug filter drops will-person-X / will-team-Y / will-manager-Z / will-someone-else- backstops; partitions with >20% placeholder fraction skipped entirely. (3) CONCENTRATED_LONGSHOT — basket trade when one leg ≥75% AND ≥2 longshots ≤8% AND portfolio return ≥25:1; rare-by-design (gates relaxed Run 8 from prior 85%/5%/50:1). EVERY OPPORTUNITY carries edge_pp_net (after slippage), kelly_fraction + kelly_fraction_half (capped at 0.25), market.liquidity, market.spread_pp, market.volume, plus a 24h-move warning ("Market moved X.Xpp in 24h") when the recent move alone exceeds the edge — your edge may already be in the price. TRADEABLE-EDGE KNOBS: min_liquidity / max_spread_pp drop opportunities where edge isn't realizable; min_partition_leg_kelly filters partitions by best per-leg Kelly. RESPONSE TOP-LEVEL: by_segment{model_driven,structural_arbitrage,concentrated_longshot}, fed_candidates/fed_note (Fed bets surface here, excluded from ranking — 1m-T vs EFFR signal is unreliable at meeting-month horizons without paid OIS/SOFR-futures data), and _diagnostics{concentrated_longshot:{...funnel counters},category_counts,filter_skips} so callers can see WHY a segment is empty (top-N stale, all candidates failed gates, knob dropped them). Cached 1h at the KV level keyed on all knobs.

ParametersJSON Schema
NameRequiredDescriptionDefault
limitNoTop N edges to return after ranking. Default 10, max 25.
windowNoPolymarket volume window to filter markets. Default 1wk.
min_kellyNoMinimum half-Kelly fraction (as decimal, e.g. 0.005 = 0.5% of bankroll) to include single-leg opportunities. Default 0 (no filter). Skips opportunities that are too small to bet sensibly even if the edge is large.
min_edge_ppNoMinimum |edge| in percentage points to include (default 0.5). Edge is evaluated NET of slippage.
slippage_ppNoAssumed execution slippage in percentage points per leg (default 0.3). Subtracted from raw |edge| before ranking and Kelly sizing. Polymarket has zero trading fees as of 2024 but bid/ask + thin depth typically eats 20-50bp per trade. Bump for very thin partitions; drop to 0 if you have a smarter fill model.
max_spread_ppNoTradeable-edge filter. Maximum bid/ask spread in percentage points on the representative market. Default null (no filter). Set to 2 to require tight books — anything wider eats most plausible edges.
min_liquidityNoTradeable-edge filter. Minimum $ liquidity on the representative market (or for partition_overround, on at least one top_leg). Default 0 (no filter). Set to 5000 to drop thin-book opportunities where executing the edge would walk the book past breakeven.
category_filterNoComma-separated list to restrict the output: "model_driven" (crypto_price + news_momentum), "structural_arbitrage" (partition_overround), "concentrated_longshot". Combine like "model_driven,structural_arbitrage". Default: all.
min_partition_leg_kellyNoMinimum BEST per-leg half-Kelly fraction across a partition_overround opportunity's top_legs (or longshot_basket legs). Default 0 (no filter). Partition arbs always return kelly_fraction_half=0 at the parent level by design (basket trades don't compose to single-leg Kelly), so min_kelly never filters them — this knob applies to the per-leg Kelly inside top_legs instead. Use to suppress thin partitions whose individual leg edges aren't worth the per-leg slippage cost.
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already indicate readOnly, idempotent, and non-destructive. The description significantly adds value beyond annotations by detailing caching ('Cached 1h at the KV level'), model families, response segments, diagnostics, and edge metrics. No contradictions with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is front-loaded with purpose and is structured into clear sections. While detailed, every sentence adds value; it could be slightly more concise but remains well-organized.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With 9 parameters, no output schema, and rich annotations, the description is exceptionally complete. It explains the response structure (by_segment, diagnostics), caching, edge metrics, Fed note, and tradeable-edge filters, covering all necessary context for agent invocation.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% with detailed parameter descriptions. The tool description does not add additional meaning for individual parameters beyond what is already in the schema. Baseline score of 3 is appropriate.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool's purpose: 'Scan top Polymarkets...return opportunities where Pipeworx data disagrees with market price.' It targets 'what should I bet on today' use case, distinguishing it implicitly from sibling tools like polymarket_arbitrage or polymarket_edge_tracker via unique functionality.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description provides context for when to use (discovering opportunities without paging) and explains tradeable-edge knobs (min_liquidity, max_spread_pp) to filter unrealistic opportunities. However, it does not explicitly mention when NOT to use or offer direct alternatives among siblings.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

polymarket_edge_trackerPolymarket Edge TrackerA
Read-onlyIdempotent
Inspect

Edge persistence and decay telemetry built from daily polymarket_edges snapshots. Answers "how long has this edge existed and is it shrinking?" — a fresh wide edge and a 3-week-old wide edge are different trades (the latter is wide for a reason nobody is willing to take). Args: days (lookback, default 14, max 30), window (snapshot family, default "1wk"). RESPONSE: tracked[] = every opportunity in the LATEST snapshot with its full edge_pp_net time-series across prior snapshots, first_seen, trend (new | widening | stable | decaying) and decay_pp_per_day (both computed on |edge_pp_net| — the value itself is signed by trade direction, negative = SELL YES); expired[] = opportunities that appeared in earlier snapshots but are GONE from the latest (closed, resolved, or arbed away) with their lifespan_days — the median lifespan is your competition clock; snapshot_dates[] = which days actually have data (snapshots are written when polymarket_edges runs on a cache-miss, so gaps mean nobody scanned that day). LIMITS: history depth is bounded by the 60-day snapshot TTL and starts from when snapshotting was enabled; decay numbers come from daily closes of edge_pp_net (net of default slippage), not intraday.

ParametersJSON Schema
NameRequiredDescriptionDefault
daysNoLookback in days (default 14, clamp 2-30).
windowNoWhich polymarket_edges window family to read snapshots for: 24hr | 1wk | 1mo (default 1wk).
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The description adds significant behavioral context beyond the annotations (readOnlyHint, etc.): it explains data sources (daily snapshots), TTL (60-day snapshot TTL), when snapshots are missing (no cache-miss scan), and that decay numbers are from daily closes, not intraday. This fully informs the agent of underlying behaviors and limitations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is fairly long but every sentence adds value. It front-loads the main purpose and then details output format and limits. Could be slightly more structured (e.g., bullet points for output fields), but remains effective and concise for the amount of information conveyed.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description fully explains the return format (tracked[], expired[], snapshot_dates[]) and key fields. It also covers limitations like TTL, start date, and data frequency. This makes the tool fully self-contained for agent invocation.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The input schema already documents both parameters with descriptions and default values. The description adds additional clarity by restating defaults and clarifying the max for days, and listing valid window options. This provides a slight improvement over the schema alone.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool provides edge persistence and decay telemetry from daily snapshots. It explicitly answers a specific trading question about edge age and trend, and distinguishes itself from the related sibling 'polymarket_edges' by focusing on historical context rather than current edges.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives context on when to use the tool (e.g., to differentiate a new wide edge from a stale one) and explains the arguments in the description. While it does not explicitly state when not to use it or list alternatives, the context is sufficient for most agents to decide appropriately.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

polymarket_fill_riskPolymarket Fill RiskA
Read-onlyIdempotent
Inspect

Realizable-vs-theoretical edge check against live CLOB order-book depth. REQUIRES one of market (single-market mode) or event (basket/partition mode). SINGLE-MARKET: pass a market slug/URL + side (buy_yes|sell_yes|buy_no|sell_no, default buy_yes) + size_usd (default 1000 — max spend on buys, target proceeds on sells); walks the ladder and returns top_of_book, vwap_fill_price, slippage_pp, shares_filled, max_fillable_usd, and a verdict (clean|degraded|cannot_fill). BASKET: pass an event slug/URL + side (sell_yes = capture overround by selling every leg, buy_yes = capture underround; default auto from partition sum) + size_usd interpreted as settlement notional S (shares per leg; each share pays $1); returns theoretical_sum vs realizable_sum (top-of-book vs VWAP across all legs), capture_ratio, profit_usd at executed size, per-leg fill detail, thin_legs[], max_clean_notional_usd, and forced_directional_risk naming the legs most likely to strand you unhedged. USE THIS before acting on any polymarket_arbitrage SELL/BUY-EVERY-LEG signal or any polymarket_edges trade above ~$500 — theoretical overround on thin books is not capturable, and partial basket fills convert an arb into an unhedged directional position (the dominant loss mode in real arb-bot P&L).

ParametersJSON Schema
NameRequiredDescriptionDefault
sideNoSingle-market: buy_yes | sell_yes | buy_no | sell_no (default buy_yes). Basket: sell_yes | buy_yes (default auto — sell if partition sum > 1, buy if < 1).
eventNoBasket mode: event slug or full polymarket.com URL — checks every leg of the partition.
marketNoSingle-market mode: market slug or full polymarket.com URL.
size_usdNoSingle-market: USD to spend (buys) or target proceeds (sells). Basket: settlement notional — shares per leg, each paying $1 at resolution. Default 1000, clamp 10–1,000,000.
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already provide read-only and idempotent hints. The description adds valuable behavioral context: it walks the order-book ladder, returns specific fields (top_of_book, vwap_fill_price, etc.), and mentions forced_directional_risk. No contradiction.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is a single dense paragraph with rich information but could be structurally improved with bullet points or clearer separation of modes. It is front-loaded with purpose.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given complexity (two modes, many return fields) and no output schema, the description adequately covers return values (top_of_book, vwap_fill_price, slippage_pp, etc.) and risks. Sufficient for an agent to understand the tool's full behavior.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, baseline 3. The description adds meaning beyond schema: explains defaults, side auto-behavior for basket, and size_usd interpretation differences between modes. Clarifies value clamp.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool performs a 'Realizable-vs-theoretical edge check against live CLOB order-book depth' and specifies two modes (single-market and basket), effectively distinguishing it from siblings like polymarket_arbitrage.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly tells when to use this tool ('before acting on any polymarket_arbitrage SELL/BUY-EVERY-LEG signal or any polymarket_edges trade above ~$500') and explains risks (theoretical overrun not capturable, partial fills cause unhedged positions).

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

polymarket_kalshi_spreadPolymarket–Kalshi SpreadA
Read-onlyIdempotent
Inspect

Cross-venue spread between Kalshi and Polymarket for the same resolving question. The two venues sometimes price the same outcome 2-25pp apart because their participant pools differ — when the bet shapes are equivalent that delta is a real signal, when they aren't the tool says so. TWO MODES: (1) topic — 10 pre-mapped macro shortcuts ("fed", "btc", "cpi", "gdp", "sp500", "recession", "next_pope", "next_uk_pm", "next_israel_pm", "2028_president") auto-fetch the matching event on each venue. (2) explicit kalshi_event_ticker + polymarket_event_slug for custom pairings. RESPONSE: each venue's leg-by-leg prices (raw probability 0-1) plus matched spread[].top_spreads_pp (Kalshi − Polymarket) where the same outcome shows up on both sides. SAFETY FIELDS: compatibility_warning fires in two cases — (a) matched_pairs:0 with skipped_cross_type>0 means the venues frame the topic with non-equivalent bet shapes (e.g. Kalshi range_bucket point-in-time vs Polymarket cumulative_threshold touch-anywhere — no arb exists), (b) matched_pairs:0 with skipped_cross_type:0 and both venues >5 legs means the token-overlap matcher found nothing in common — events likely semantically unrelated despite the topic keyword. temporal_alignment{polymarket_month,kalshi_month,aligned} tells you whether the two events resolve in the same calendar period; aligned:false means spreads are mathematically meaningless across the temporal gap. skipped_cross_type / skipped_cross_subtype counters expose how many leg-pair comparisons were dropped (cross-type = metric_type mismatch like MoM vs YoY; cross-subtype = inequality mismatch like cum_ge vs cum_le). Real cross-venue spreads are rarer than the macro-shortcut list suggests — most pre-mapped topics return compatibility_warning today; pre-mapped ≠ tradeable.

ParametersJSON Schema
NameRequiredDescriptionDefault
topicNoPre-mapped: fed | btc | cpi | gdp | sp500 | recession | next_pope | next_uk_pm | next_israel_pm | 2028_president
kalshi_event_tickerNoExplicit Kalshi event ticker, e.g. "KXFED-26OCT". Overrides the topic-mapped Kalshi side.
polymarket_event_slugNoExplicit Polymarket event slug, e.g. "fed-decision-in-june-825". Overrides the topic-mapped Polymarket side.
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The description discloses all behavioral traits: two modes, response format (leg prices, top_spreads_pp), safety fields (compatibility_warning cases), temporal alignment, and skipped cross types. This goes far beyond the annotations, which only state read-only, idempotent, and non-destructive.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is longer than average but well-structured with paragraphs, bullet-style lists, and bolded key terms. It front-loads the core purpose and efficiently covers edge cases. Could be trimmed slightly but is appropriately sized for the complexity.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Despite having no output schema, the description fully defines the response structure (leg prices, top_spreads_pp, compatibility_warning, temporal_alignment, skipped counters). Together with the parameter descriptions, it provides complete context for using this complex cross-venue tool.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so the baseline is 3. The description adds value by explaining the topic mode with concrete shortcut examples and clarifying the explicit mode parameters, making it a 4.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description immediately states the tool's purpose: 'Cross-venue spread between Kalshi and Polymarket for the same resolving question.' It distinguishes itself from sibling tools like polymarket_arbitrage by focusing on cross-venue comparison.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly explains two modes (topic and explicit), provides a list of pre-mapped macros, and offers guidance on when spreads are meaningful vs. not, including compatibility warnings and temporal alignment.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

recallRecallA
Read-onlyIdempotent
Inspect

Retrieve a value previously saved via remember, or list all saved keys (omit the key argument). Use to look up context the agent stored earlier — the user's target ticker, an address, prior research notes — without re-deriving it from scratch. Scoped to your identifier (anonymous IP, BYO key hash, or account ID). Pair with remember to save, forget to delete.

ParametersJSON Schema
NameRequiredDescriptionDefault
keyNoMemory key to retrieve (omit to list all keys)
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint=true, destructiveHint=false. Description adds scoping to identifier and behavior when omitting key. No contradictions.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Three sentences cover main function, usage context, and scope. Front-loaded and efficient with no extraneous detail.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Simple tool with one optional param, no output schema, and annotations cover safety. Description explains return behavior, scope, and tool pairing completely.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% with description for key. Description adds: 'omit the key argument' to list all keys, reinforcing schema behavior.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

Description clearly states 'Retrieve a value previously saved via remember, or list all saved keys (omit the key argument).' Verb and resource are specific, and it distinguishes from sibling tools 'remember' and 'forget'.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly says 'Use to look up context the agent stored earlier' with examples like ticker, address, notes. Indicates alternative to re-deriving and pairs with remember/forget.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

recent_alertsRecent AlertsA
Read-onlyIdempotent
Inspect

Pull fired events from your subscription feed. Returns the most recent alerts the evaluator has written to your persisted feed — each carries source, citation_uri (pipeworx:// when available), and the raw event payload. Filter by type (e.g. "sec_8k") and/or since (ISO timestamp). Set mark_read:true to flag returned events read so the next call only shows newer ones. Polls work fine; the same feed is also at GET registry.pipeworx.io/alerts.json for scripts and dashboards.

ParametersJSON Schema
NameRequiredDescriptionDefault
typeNoOptional — filter to one subscription type.
limitNoMax events to return (1-200, default 50).
sinceNoOptional ISO timestamp — return events fired_at >= this time.
mark_readNoFlag the returned events read in the same call (default false).
unread_onlyNoReturn only events where read_at is null (default false).
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations indicate readOnlyHint, idempotent, and non-destructive. The description adds that setting mark_read:true flags events as read, affecting subsequent calls, and confirms that polling works. This provides useful behavioral context beyond the annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is concise, with every sentence adding value. It is front-loaded with the main purpose and efficiently covers features, alternatives, and usage notes in just a few sentences.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Despite no output schema, the description specifies the return fields (source, citation_uri, raw payload) and covers key behaviors (filtering, mark_read, polling). It also provides an external access point, making it self-contained and complete for a list tool.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema covers all 5 parameters, so baseline is 3. The description adds value by explaining the effect of mark_read (flag events read) and providing an example filter for 'type' ('sec_8k'), enhancing understanding beyond the schema's short descriptions.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool's function: pulling fired events from the subscription feed with specific fields (source, citation_uri, payload). It effectively distinguishes itself from sibling tools like 'list_subscriptions' and others by focusing on recent alert events from a persisted feed.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description provides usage context (filtering by type and since, using mark_read) and mentions an alternative access method via a direct GET endpoint. However, it does not explicitly state when to prefer this tool over others, though no similarly purposed sibling exists.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

recent_changesRecent ChangesA
Read-onlyIdempotent
Inspect

"What's new with X" / "latest on Y" / "what happened to Z this week / month / quarter" / "updates on Acme" / "news on Tesla recently" / "what's happening with Apple" — change feed for a company in the last N days/weeks/months in ONE parallel call. Fans out to SEC EDGAR (filings since since), GDELT→GNews fallback (news mentions in window — GDELT preferred, GNews when rate-limited or 5xx), USPTO (patents granted; PatentsView API sunset May 2025 so this soft-fails until reactivated). since accepts ISO date ("2026-04-01") or relative shorthand ("7d", "30d", "3m", "1y"). Returns structured changes[] grouped by source + total_changes count + pipeworx:// citation URIs. Use entity_profile instead when you want the static profile (filings + fundamentals + LEI + patents) regardless of window.

ParametersJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type. Only "company" supported today.
sinceYesWindow start — ISO date ("2026-04-01") or relative ("7d", "30d", "3m", "1y"). Use "30d" or "1m" for typical monitoring.
valueYesTicker (e.g., "AAPL") or zero-padded CIK (e.g., "0000320193").
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, idempotentHint, and destructiveHint. The description adds significant detail: fans out to multiple sources (SEC, GDELT/GNews, USPTO), explains fallback logic, and describes the return structure (changes[], total_changes, citation URIs). No contradiction.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is a single, well-organized paragraph that loads the primary purpose and examples first, then details sources, parameters, return values, and finally an alternative tool. Every sentence provides essential information without redundancy.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Despite having no output schema, the description fully describes the return structure and behavior. It covers all three parameters exhaustively, explains multi-source fan-out and fallbacks, and provides a clear alternative for different use cases. Complete for a read-only query tool.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, but the description enhances parameter understanding: specifies that 'since' accepts ISO dates or relative shorthand (e.g., '7d', '30d'), recommends '30d' or '1m' for typical monitoring, and explains the 'type' parameter only supports 'company'. This adds practical guidance beyond the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool provides a change feed for a company over a specified window, with concrete example queries. It explicitly distinguishes from the sibling tool 'entity_profile' by noting that tool is for static profiles regardless of window.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explains when to use this tool vs. alternatives, specifically recommending 'entity_profile' for static profiles. It also clarifies fallback behavior between GDELT and GNews and notes the soft-fail for USPTO, giving clear usage context.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

rememberRememberA
Idempotent
Inspect

Save data the agent will need to reuse later — across this conversation or across sessions. Use when you discover something worth carrying forward (a resolved ticker, a target address, a user preference, a research subject) so you don't have to look it up again. Stored as a key-value pair scoped by your identifier. Authenticated users get persistent memory; anonymous sessions retain memory for 24 hours. Pair with recall to retrieve later, forget to delete.

ParametersJSON Schema
NameRequiredDescriptionDefault
keyYesMemory key (e.g., "subject_property", "target_ticker", "user_preference")
valueYesValue to store (any text — findings, addresses, preferences, notes)
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations indicate idempotentHint=true and destructiveHint=false. The description adds context about scoping (by agent identifier), persistence (authenticated vs anonymous sessions), and retention duration (24 hours), which go beyond annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is concise with about five sentences, front-loading the purpose and usage, then adding details. Every sentence adds value without redundancy.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a simple key-value save tool with no output schema, the description covers all necessary context: purpose, usage, scoping, persistence, and pairing with siblings. No gaps.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% with clear descriptions for key and value. The description reinforces the purpose but does not add significant new meaning beyond what the schema provides.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the purpose: 'Save data the agent will need to reuse later.' It provides specific verb-resource combination and mentions sibling tools (recall, forget) to differentiate.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly says when to use: 'when you discover something worth carrying forward.' It also provides alternatives by directing to recall and forget for complementary operations.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

resolve_entityResolve EntityA
Read-onlyIdempotent
Inspect

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI when a ticker is implied; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, or company name as input), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

ParametersJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin").
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare read-only and idempotent behavior. The description adds valuable context: the internal cascade through multiple endpoints, graceful degradation of LEI/FIGI enrichment, source labeling for identifiers, and explicit reporting of unresolved identifiers. This is beyond what annotations provide.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but well-structured: query examples first, then the main purpose, then detailed type-specific behavior. Every sentence adds value, though it could be tightened without losing essential information.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description compensates thoroughly. It details return values for each type (SEC EDGAR IDs, LEI, FIGI, RxCUI, ingredient, brand), source labeling, unresolved handling, and graceful degradation—complete enough for an agent to understand what to expect.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% with clear parameter descriptions. The description reinforces `value` semantics with examples (ticker/CIK/name for company; brand/generic for drug) and adds what each type returns (CIK, ticker, LEI, FIGI, RxCUI, etc.), enriching meaning beyond the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool's function: resolving user-spoken names to canonical identifiers. It provides concrete query examples ('ticker for...', 'find the CIK for...') and lists supported entity types (company, drug), distinguishing it from siblings that likely consume those identifiers.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicit guidance is given: 'Use FIRST whenever you have a name but need an ID.' This defines the primary use case and implies when to use this tool over alternatives. It also notes that it replaces 2-3 manual lookups, further clarifying its role.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

scan_competitor_ai_presenceScan Competitor AI PresenceA
Read-onlyIdempotent
Inspect

Compare AI visibility across multiple entities side-by-side. Probes each entity (your brand + N competitors) with ai_visibility_check, ranks by score, surfaces which is most/least recognized. Useful for competitive AI-marketing audits: "does Claude know about us as well as our competitors?". Returns ranked list with score, confidence, signal density per entity.

ParametersJSON Schema
NameRequiredDescriptionDefault
modelsNoWhich models to probe. Supported: "workers-ai" (free default), "anthropic" (requires _apiKey). Omit for just workers-ai.
_apiKeyNoOptional Anthropic API key — only if "anthropic" is in models. Passed to api.anthropic.com per probe.
contextNoOptional shared context applied to every probe (e.g. "B2B SaaS", "Boston restaurant"). Disambiguates common names.
entitiesYesArray of 2-8 entities to compare (brand/business/product names). First entry treated as the "subject" for narrative; rest are competitors.
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, idempotentHint, openWorldHint. The description adds that it probes each entity, ranks by score, and returns a ranked list. It could mention potential time or cost when using Anthropic model, but overall adds relevant process details.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Three sentences efficiently cover purpose, method, use case, and output. Every sentence adds value, no fluff. Front-loaded with key functionality.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Even without an output schema, the description explains the return format (ranked list with score, confidence, signal density per entity). It covers multi-entity probing, ranking, and extremes. Parameters and usage are well-explained. No gaps.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% with descriptions for all parameters. The description adds meaningful context beyond schema: first entity is treated as subject, models supported, and context disambiguation. This helps the agent use parameters correctly.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool compares AI visibility across multiple entities side-by-side, probes each with ai_visibility_check, ranks by score, and surfaces most/least recognized. It distinguishes from sibling ai_visibility_check by emphasizing multi-entity comparison.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description provides a concrete use case (competitive AI-marketing audits) and an example question. It implies usage for multiple entities but does not explicitly say when not to use it or mention alternatives for single entities.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

scan_dependencyScan DependencyA
Read-onlyIdempotent
Inspect

Composite "should I add this npm package to my project" check in ONE call — fans out across deps.dev (license + advisories + version history) and bundlephobia (gzipped/minified bundle size, dependency count, ESM/tree-shake support). Use whenever an agent asks "is X safe / popular / small" or "what does adding lodash cost me". Returns a summary block (is_latest, license, published_at, advisory_count, bundle_kb_min, bundle_kb_gz, dependency_count, has_esm, tree_shakeable), per-advisory detail, links, and a list of recent alternative versions. NPM ecosystem only in v1; PyPI / Maven / Cargo / Go fall under deps.dev:version directly. Partial failures degrade gracefully — bundlephobia's first measurement on a new version can take 5-30s; sources_failed will list it if it times out, the rest still returns.

ParametersJSON Schema
NameRequiredDescriptionDefault
packageYesnpm package name. Scoped packages (e.g. "@types/node") are accepted.
versionNoSpecific version to check (e.g., "18.3.1"). Defaults to the latest published version when omitted.
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint=true, idempotentHint=true, destructiveHint=false. Description adds valuable context: partial failures degrade gracefully, bundlephobia first measurement can take 5-30s, sources_failed lists timeouts. No contradictions.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Description is detailed but front-loaded with purpose and use cases. It includes important caveats without being overly verbose. Could be slightly more concise but still effective.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Despite no output schema, description fully explains the return summary block (is_latest, license, etc.), per-advisory detail, links, and alternative versions. Also covers failure modes and ecosystem limitations, making agent invocation robust.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%, so baseline is 3. Description adds minimal extra meaning beyond schema: only mentions that scoped packages are accepted. Does not elaborate on version format or defaults beyond schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states it's a composite check for npm packages covering deps.dev and bundlephobia. It uses specific verbs ('scan', 'check') and distinguishes itself from sibling tools which focus on other domains.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly says 'Use whenever an agent asks "is X safe / popular / small" or "what does adding lodash cost me"'. Also notes NPM-only in v1 and provides alternative for other ecosystems ('PyPI / Maven / Cargo / Go fall under deps.dev:version directly').

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

search_withinSearch Within a SourceA
Read-onlyIdempotent
Inspect

Semantic search INSIDE a fetched record. Pass the text you already pulled (e.g. a SEC 10-K body, an article, a long tool result) plus a natural-language query; get back the top-N passages with character offsets and similarity scores. Use when the record is too big to cram into the prompt — search_within saves context, returns only the passages that matter, and every passage carries an offset so the agent can verify a verbatim quote. Pairs with ask_pipeworx_grounded: fetch with the gateway, ground over the relevant passages instead of the whole document. BGE-base-en embeddings + cosine over 500-char overlapping windows; cap is 200K chars (longer inputs are truncated and flagged).

ParametersJSON Schema
NameRequiredDescriptionDefault
textYesThe document text to search inside (max ~200K chars).
limitNoMax passages to return (1-20, default 5).
queryYesNatural-language query — what passages do you want? E.g. "supply-chain risk", "fiscal year 2024 revenue", "drug interactions with warfarin".
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already provide readOnlyHint, openWorldHint, idempotentHint, destructiveHint. Description adds valuable details not in annotations: embedding model (BGE-base-en), window size (500-char overlapping), character limit (200K chars with truncation flag).

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Description is three sentences; first states purpose, second gives usage guidance, third technical details. Efficient but could be slightly tighter. No wasted words.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

No output schema, but description explains return values (passages with offsets and scores). Covers input constraints, usage guidance, pairing with sibling, and technical details (model, window, cap). Complete for a search tool.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% (all params described in schema). Description adds practical context: text max chars, limit default (5) and range (1-20), query examples. Adds value beyond schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool does 'semantic search INSIDE a fetched record,' specifies inputs (text and query), outputs (top-N passages with offsets and scores), and distinguishes it from sibling tools like ask_pipeworx_grounded.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly says 'Use when the record is too big to cram into the prompt' and describes pairing with ask_pipeworx_grounded. Does not explicitly list when not to use, but the context is clear enough.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

subscribeSubscribe to AlertsA
Idempotent
Inspect

Create a proactive monitoring subscription to a live-data event stream. Returns the new subscription id. Requires a Pipeworx OAuth account (anonymous + BYO cannot persist subscriptions). Supported types: "sec_8k" (8-K filings matching ticker + item codes — e.g. items:["5.02"] = officer change), "polymarket_edge" (Polymarket↔Kalshi cross-venue mispricings — params:{topic:"fed"}), "fred_series" (new FRED observations — params:{series_id:"UNRATE"}). Delivery channels: feed (always on — pull via recent_alerts or GET registry.pipeworx.io/alerts.json), and optionally email (set delivery:{email:"you@x.com"}) or sms (delivery:{sms:"+15551234567"} — phone must be verified at /account first; 10/day cap).

ParametersJSON Schema
NameRequiredDescriptionDefault
typeYesSubscription type.
paramsYesType-specific filter. sec_8k: {ticker:"AAPL", items?:["5.02","1.01"]}. polymarket_edge: {topic:"fed", min_spread_bps?:500}. fred_series: {series_id:"UNRATE"}. patent_grant: {applicant:"Apple Inc."}. clinical_trial: {sponsor?:"Pfizer", condition?:"lung cancer", phase?:"PHASE3"} (sponsor or condition required).
deliveryNoOptional delivery channels in addition to the always-on persistent feed. {email:"you@x.com"} sends a templated alert per fired event. {sms:"+15551234567"} sends an SMS per event — must match the verified phone on the caller's account (verify at https://pipeworx.io/account first; 10/day cap). {webhook:"https://..."} POSTs each event JSON to your endpoint, HMAC-signed — the response includes delivery.webhook_secret (whsec_…) ONCE; verify X-Pipeworx-Signature = sha256 HMAC of "<X-Pipeworx-Timestamp>.<raw body>". Auto-disabled after 10 consecutive failing runs.
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already indicate non-destructive and idempotent behavior. Description adds rich behavioral context: account requirements, type-specific parameters, delivery channels, SMS cap, webhook signing, and auto-disable on failures. No contradictions with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Description is fairly long but well-structured with bullet points and clear separation of types and delivery options. Every sentence adds value; could be slightly shorter but still effective.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool's complexity (3 params with nested objects, multiple enum types, delivery options, no output schema), the description is extremely complete. It explains return value, covers all types, and notes additional requirements.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, and description adds substantial meaning: explains each type's params with examples and clarifies constraints (e.g., sponsor or condition required for clinical_trial).

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

Description clearly states the tool creates a proactive monitoring subscription to a live-data event stream and returns the subscription id. It lists supported types and distinguishes from siblings like 'list_subscriptions' and 'unsubscribe'.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Provides clear when-to-use guidance and prerequisites (Pipeworx OAuth account, phone verification for SMS). Lacks explicit when-not-to-use but context is sufficient.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

suggest_questionsWhat Can I Ask Pipeworx?A
Read-onlyIdempotent
Inspect

What can I ask Pipeworx? / what is Pipeworx good for? / what can you do? / give me ideas / show me examples / getting started / what data do you have? — the onboarding entry point for an agent that just connected and wants to know what is worth asking. Returns category-bucketed example questions (company financials, drugs & clinical trials, economics, real estate, prediction markets, weather, government & patents, science & academia, news) — each with the exact tool + argument shape that answers it, drawn from the live catalog of thousands of tools. Call with no arguments for the full spread, or pass topic (e.g. "finance", "pharma", "betting") to focus. Use this FIRST when you do not yet know what Pipeworx can do for you, or to learn how to call the meta-tools (ask_pipeworx, entity_profile, compare_entities, etc.).

ParametersJSON Schema
NameRequiredDescriptionDefault
topicNoOptional focus area: finance | pharma | economics | real-estate | betting | weather | government | science | news. Omit for a cross-category spread.
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, openWorldHint, idempotentHint, destructiveHint. The description adds behavioral context: it returns example questions, organizes them by category, and mentions the response includes exact tool+argument shapes. This goes beyond the annotations without contradicting them.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is a single paragraph that front-loads alternative phrasings, then explains output and usage. Every sentence contributes meaningful information, though it could be slightly more compact. Overall well-structured.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For an onboarding tool with no output schema, the description fully explains what the tool returns (category-bucketed example questions with tool+argument shapes) and when to use it. It covers all necessary context given the simple input schema.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The schema covers the single optional parameter 'topic' with a description. The description reinforces it and adds practical advice: 'Call with no arguments for the full spread, or pass topic... to focus.' This adds value beyond the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states what the tool does: it returns category-bucketed example questions to help users understand what they can ask Pipeworx. It distinguishes itself from sibling tools like ask_pipeworx or entity_profile by being the first entry point for onboarding.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly says 'Use this FIRST when you do not yet know what Pipeworx can do for you, or to learn how to call the meta-tools'. Provides guidance on when to call with no arguments vs. passing a topic parameter.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

unsubscribeUnsubscribe from AlertsA
Idempotent
Inspect

Cancel a subscription by id. Ownership is enforced — you can only cancel your own subscriptions. The row is deactivated (not deleted) so its historical events stay available via recent_alerts.

ParametersJSON Schema
NameRequiredDescriptionDefault
idYesSubscription id (uuid) returned by subscribe.
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Discloses ownership enforcement (auth) and deactivation behavior, adding context beyond annotations. Consistent with idempotentHint and destructiveHint.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Two sentences, front-loaded with the action, efficient and clear without extraneous content.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given simple tool with single parameter, rich annotations, and no output schema, the description provides complete context for usage.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% with clear parameter description ('Subscription id (uuid) returned by subscribe'). Description adds no further parameter-specific information, meeting baseline.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

Description uses specific verb 'cancel' with resource 'subscription', clearly stating what the tool does. It distinguishes itself from sibling tools like 'subscribe' and 'list_subscriptions'.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

States ownership enforcement, guiding who can use it. Explains the deactivation behavior, but does not explicitly list when not to use or alternatives.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

validate_claimValidate ClaimA
Read-onlyIdempotent
Inspect

"Is it true that…" / "fact check" / "verify the claim that…" / "did X really…" / "was Y actually…" / "confirm or refute" / "true or false" — natural-language claim verification against authoritative sources. Use whenever the agent needs to check whether something a user said is factually correct. Company-financial claims (revenue, net income, cash for public US companies) verify via the structured SEC EDGAR + XBRL fast path with exact percent-delta math; ANY OTHER factual claim (macro statistics, rates, prices, drug data, records) automatically falls through to the grounded pipeline — routed to the right live source, answered with verbatim evidence, then judged. Returns a verdict (confirmed / approximately_correct / refuted / inconclusive / unsupported / could_not_verify), the grounded or structured actual value with pipeworx:// citation, and reasoning. IMPORTANT for callers: could_not_verify means the check did not happen (our LLM or source failed) and carries verification_error{stage,detail} — it is NOT evidence for or against the claim, and must not be shown as one. unsupported means we looked and cover no source for it. Replaces 4–6 sequential calls (NL parsing → entity resolution → data lookup → comparison).

ParametersJSON Schema
NameRequiredDescriptionDefault
claimYesNatural-language factual claim, e.g., "Apple's FY2024 revenue was $400 billion" or "Microsoft made about $100B in profit last year".
tolerance_pctNoMax percent deviation still graded approximately_correct (0.5–50). Overrides the tolerance implied by the claim wording — set 1–2 for hallucination detection where any material error must be refuted. Default: implied by wording, capped at 5.
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the readOnly/openWorld/idempotent annotations, the description discloses critical behaviors: could_not_verify means the check failed and must not be treated as evidence, unsupported means no source was found, and results include citations and reasoning. It also explains the internal routing logic and that the tool replaces multiple sequential calls.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but every segment earns its place: trigger examples, usage rule, dual-path explanation, verdict list, and critical caveats about error states. It is front-loaded with the core purpose and well-structured, though it could be tightened without losing value.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Without an output schema, the description fully covers the return contract: verdicts, actual value with citation, reasoning, and the meaning of every verdict, including error details. It also explains the underlying pipeline and edge cases, giving the agent a complete mental model of what the tool does and when results are trustworthy.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The schema already documents both parameters fully, giving a baseline of 3. The description adds concrete operational guidance: tolerance_pct overrides the tolerance implied by claim wording, is capped at 5 by default, and should be set to 1–2 for hallucination detection. This useful context goes beyond the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool performs natural-language claim verification against authoritative sources, with explicit trigger phrases like 'fact check' and 'verify the claim that…'. It distinguishes a financial fast path from a grounded pipeline, giving the tool a unique, well-scoped purpose among siblings.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It explicitly says 'Use whenever the agent needs to check whether something a user said is factually correct,' and differentiates when to use the SEC fast path versus the grounded pipeline. It lacks explicit alternatives or exclusion guidance, so it doesn't fully score 5, but the context is strong.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Discussions

No comments yet. Be the first to start the discussion!

Related MCP Servers

  • A
    license
    A
    quality
    D
    maintenance
    A Model Context Protocol (MCP) server for querying drug information from the OpenFDA API. Features Retrieve drug label information by brand name Retrieve drug information by generic (active ingredient) name Get all brand versions of a generic drug Get adverse event (side effect) reports for a drug
    7
    65
    4
    MIT
  • F
    license
    B
    quality
    D
    maintenance
    A comprehensive MCP server that provides access to U.S. FDA public datasets via the openFDA API, enabling querying of drug adverse events, labeling, recalls, approvals, shortages, NDC directory, and medical device regulatory data.
    10
    21
  • A
    license
    A
    quality
    B
    maintenance
    An MCP server that enables AI assistants to query U.S. FDA public datasets, including drug adverse events, labeling, recalls, approvals, shortages, NDC directory, and medical device regulatory information.
    10
    MIT

View all MCP Servers

Try in Browser

Your Connectors

Sign in to create a connector for this server.